{"gene":"NRF1","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2006,"finding":"Nrf1 is targeted to the endoplasmic reticulum via its N-terminal domain (NTD, amino acids 1-124), which negatively regulates its activity by anchoring it to the ER. Keap1 does not control Nrf1 activity or subcellular distribution, distinguishing Nrf1 regulation from Nrf2. Attachment of the NTD to Nrf2 redirected Nrf2 from the nucleus to the ER.","method":"Immunocytochemistry with ER marker co-localization, ectopic expression of wild-type and deletion mutants in wild-type and mutant MEFs, domain-swap experiments","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (immunocytochemistry, mutagenesis, domain-swap) in single rigorous study","pmids":["16872277"],"is_preprint":false},{"year":2016,"finding":"The aspartyl protease DDI2 (DNA-damage inducible 1 homolog 2) is required to proteolytically cleave and activate Nrf1 in response to proteasome dysfunction. Deletion of DDI2 reduced the cleaved form of Nrf1 and impaired proteasome subunit upregulation; protease-dead DDI2 could not rescue these defects.","method":"DDI2 knockout cell lines, add-back of wild-type vs. protease-dead DDI2 mutant, western blot for Nrf1 cleavage forms, proteasome activity assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 — genetic deletion plus protease-dead rescue experiment; independently replicated in two simultaneous publications (PMID 27528192 and 27528193)","pmids":["27528193","27528192"],"is_preprint":false},{"year":2016,"finding":"In C. elegans, ER-associated SKN-1A/Nrf1 is activated by the aspartic protease DDI-1, which cleaves it following proteasome dysfunction. Genes required for SKN-1A activation include regulators of ER traffic and a peptide N-glycanase, establishing a conserved ER-to-nucleus proteasome surveillance pathway.","method":"Comprehensive genetic screen (C. elegans), epistasis analysis, protease requirement assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — comprehensive genetic epistasis in C. elegans ortholog; conserved mechanism confirmed in parallel mammalian work","pmids":["27528192"],"is_preprint":false},{"year":2015,"finding":"mTORC1 activation promotes NRF1-dependent transcriptional upregulation of proteasome subunit genes, increasing cellular proteasome content. This was demonstrated through genetic activation of mTORC1 (TSC loss-of-function) as well as physiological stimuli (growth factors, feeding).","method":"Genetic loss-of-function (TSC knockout), pharmacological mTORC1 inhibition with rapamycin, NRF1 knockdown, proteasome content measurements","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic KO with defined cellular phenotype, but single lab report","pmids":["26017155"],"is_preprint":false},{"year":2015,"finding":"DNA methylation competes with NRF1 binding in vivo; NRF1 occupies thousands of additional sites in unmethylated genomes. Restoring de novo methyltransferase activity initiates remethylation at NRF1-bound sites and outcompetes NRF1 binding. Removal of neighboring motifs in cis or a cooperating TF in trans causes local hypermethylation and loss of NRF1 binding.","method":"DNase-I hypersensitive site mapping in murine stem cells with/without DNA methylation, genetic manipulation of methyltransferases, motif deletion experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide mapping with multiple orthogonal genetic manipulations; published in high-impact journal","pmids":["26675734"],"is_preprint":false},{"year":2018,"finding":"O-GlcNAc transferase (OGT) and host cell factor C1 (HCF-1) form a complex with NRF1; O-GlcNAcylation catalyzed by OGT stabilizes NRF1 and is essential for NRF1-mediated upregulation of proteasome subunit genes. OGT inhibition sensitized cancer cells to proteasome inhibitors in vitro and in xenograft models.","method":"Immunoprecipitation and mass spectrometry, OGT inhibition, xenograft mouse model, meta-analysis of cancer proteomics data","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP/MS identification plus functional in vivo validation","pmids":["29941490"],"is_preprint":false},{"year":2017,"finding":"Nrf1 is negatively regulated by O-GlcNAcylation via OGT interaction through HCF-1; O-GlcNAcylation decreases Nrf1 protein stability and transactivation activity by promoting ubiquitination. The PEST2 degron within Nrf1 is identified as the O-GlcNAcylation site.","method":"Co-immunoprecipitation, OGT overexpression, proteasomal inhibition, ubiquitination assays, domain mapping","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with functional follow-up; single lab but multiple methods","pmids":["28625484"],"is_preprint":false},{"year":2015,"finding":"Nrf1 O-GlcNAcylation by OGT negatively regulates Nrf1/TCF11 protein stability and transactivation activity, promoting ubiquitination and turnover. This effect is glucose-concentration dependent.","method":"OGT interaction identified by pulldown, co-immunoprecipitation, ubiquitination assays, reporter assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP/pulldown with functional follow-up; replicated in PMID 28625484","pmids":["26231763"],"is_preprint":false},{"year":2016,"finding":"Under conditions of complete proteasome blockade, Nrf1 (p120) can still be retrotranslocated into the cytosol and proteolytically cleaved to the active p110 form in a proteasome-independent manner, indicating a proteasome-independent processing pathway exists.","method":"Complete proteasome active-site inhibition, subcellular fractionation, western blot for Nrf1 processing forms, transcription reporter assays","journal":"Current biology : CB","confidence":"Medium","confidence_rationale":"Tier 2 — clean biochemical demonstration with complete proteasome blockade; single lab","pmids":["27676297"],"is_preprint":false},{"year":2024,"finding":"SCFFBS2 (an N-glycan-recognizing E3 ligase) cooperates with the RBR-type E3 ligase ARIH1 to ubiquitinate Nrf1 through oxyester bonds (non-canonical ubiquitination) at N-GlcNAc residues generated by ENGASE. This atypical ubiquitin chain assembly requires UBE2L3 and inhibits DDI2-mediated Nrf1 activation.","method":"In vitro reconstitution of polyubiquitination on glycopeptides, cell-based ubiquitination assays, mass spectrometry, mutagenesis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution plus mutagenesis plus cell-based validation","pmids":["39116872"],"is_preprint":false},{"year":2019,"finding":"SIAH2, a hypoxia-activated E3 ubiquitin ligase, degrades NRF1 through ubiquitination on lysine 230, reducing nuclear-encoded mitochondrial gene expression including pyruvate dehydrogenase beta, promoting the Warburg effect and metabolic reprogramming.","method":"Ubiquitination assays, site-directed mutagenesis (K230), hypoxia experiments, gene expression profiling, tumor microenvironment analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — specific ubiquitination site identified with mutagenesis and functional consequence demonstrated","pmids":["30833558"],"is_preprint":false},{"year":2019,"finding":"ATM, when activated by oxidative stress (but not by DNA damage), phosphorylates NRF1, leading to NRF1 dimerization, nuclear translocation, and upregulation of nuclear-encoded mitochondrial genes to enhance electron transport chain capacity and restore mitochondrial function.","method":"ATM activation assays distinguishing oxidative vs. DNA damage stimuli, phosphorylation assays, subcellular fractionation, mitochondrial function assays in ATM-null cells","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — specific kinase-substrate relationship with mechanistic dissection of stimulus type; multiple orthogonal assays","pmids":["30642892"],"is_preprint":false},{"year":2021,"finding":"PGC-1α and NRF1 transcriptionally upregulate FUNDC1 (a mitophagy receptor) by NRF1 binding to the consensus site in the Fundc1 promoter, coupling mitochondrial biogenesis with mitophagy. Specific knockout of Fundc1 in BAT impaired mitochondrial turnover and adaptive thermogenesis.","method":"ChIP demonstrating NRF1 binding to Fundc1 promoter, conditional knockout mouse, mitochondrial function assays, thermogenesis phenotyping","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP with direct promoter binding plus conditional KO with defined metabolic phenotype","pmids":["33554448"],"is_preprint":false},{"year":2018,"finding":"Cold adaptation induces Nrf1 in brown adipose tissue (BAT) to increase proteasomal activity, which is crucial for maintaining ER homeostasis during thermogenic activity. Brown-adipocyte-specific deletion of Nrf1 caused ER stress, tissue inflammation, diminished mitochondrial function, and BAT whitening under thermogenic conditions.","method":"Tissue-specific conditional knockout mouse, cold exposure experiments, proteasome activity assays, ER stress markers, mitochondrial function measurements","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with multiple defined mechanistic readouts","pmids":["29400713"],"is_preprint":false},{"year":2018,"finding":"NGLY1 regulates mitochondrial homeostasis through NRF1; NGLY1-deficient cells show impaired mitophagy and fragmented mitochondria with cGAS-STING and MDA5-MAVS pathway activation. Pharmacological activation of NRF2 (a non-glycosylated homolog) restores mitochondrial homeostasis in NGLY1-deficient cells.","method":"NGLY1 knockout human and mouse cells, mitophagy assays, innate immune pathway activation measurements, NRF1 functional rescue experiments","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — KO in multiple cell types with mechanistic pathway delineation and rescue","pmids":["30135079"],"is_preprint":false},{"year":2003,"finding":"Nrf1 is essential for hepatocyte survival during development; Nrf1-deficient cells contributed to fetal but not adult liver. Loss of Nrf1 caused liver cell apoptosis, increased oxidative stress, impaired antioxidant gene expression, and sensitized cells to TNF-mediated cytotoxicity.","method":"Chimeric mouse analysis, primary hepatocyte culture, oxidative stress measurements, antioxidant gene expression assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo chimera analysis plus primary cell functional assays; clean loss-of-function with defined phenotype","pmids":["12808106"],"is_preprint":false},{"year":2003,"finding":"Nrf1 and Nrf2 have overlapping functions in antioxidant gene expression during early development; compound Nrf1/Nrf2 double-knockout mice die at E9-10 with extensive apoptosis and severely impaired antioxidant defense gene expression compared with single knockouts. Cell death was mediated by ROS activation of p53/Noxa.","method":"Double-knockout mouse generation, reactive oxygen species measurement, antioxidant gene expression, rescue by reduced oxygen or antioxidants, p53/Noxa induction assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via double-KO with multiple mechanistic readouts","pmids":["12968018"],"is_preprint":false},{"year":2005,"finding":"Nrf1 and Nrf2 regulate rat GCLC transcription indirectly by modulating the expression of key AP-1 (c-Jun, c-Fos) and NF-κB (p50, p65) family members. Overexpression of Nrf1 or Nrf2 restored GCLC promoter activity but not if AP-1 and NF-κB binding sites were mutated.","method":"Nrf1/Nrf2 null fibroblasts, reporter gene assays with site-directed mutagenesis, mRNA/protein expression analysis, nuclear binding activity assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis of response elements plus null-cell rescue; multiple orthogonal approaches","pmids":["15988009"],"is_preprint":false},{"year":2014,"finding":"Liver-specific Nrf1 knockout causes lipid accumulation in hepatocytes with altered fatty acid composition due to upregulation of FA metabolism genes. Nrf1 normally suppresses the cystine/glutamate antiporter xCT by occupying an ARE in its promoter; upon severe oxidative stress, Nrf1 is displaced and Nrf2 is recruited.","method":"Inducible liver-specific Nrf1 knockout mouse, lipid analysis, gene expression profiling, ARE reporter assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — conditional KO mouse with detailed molecular mechanism including promoter occupancy studies","pmids":["25092871"],"is_preprint":false},{"year":2016,"finding":"Small Maf (sMaf) proteins are indispensable heterodimeric partners for Nrf1 in the liver; liver-specific sMaf triple-deficient mice recapitulate the Nrf1 liver-specific KO phenotype (hepatic steatosis, dysregulation of metabolic and proteasomal genes), providing genetic evidence that sMaf proteins mediate Nrf1 function.","method":"Liver-specific conditional sMaf triple-knockout mice, gene expression profiling, phenotypic comparison with Nrf1 KO","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via conditional triple-KO recapitulating Nrf1 phenotype","pmids":["27723178"],"is_preprint":false},{"year":2022,"finding":"The Nrf1-MafG heterodimer binds CNC-sMaf-binding elements (CsMBEs) to activate proteasome subunit genes and broader proteostasis-related genes (ER-associated degradation, chaperone, ubiquitin-mediated degradation pathways). SINE B2 transposable elements harbor CsMBEs and contribute to target gene diversity.","method":"Tethered Nrf1-MafG heterodimer in small Maf triple-knockout fibroblasts, ChIP-seq, RNA-seq","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide binding and transcriptome analysis with engineered heterodimer system","pmids":["35129372"],"is_preprint":false},{"year":2021,"finding":"NRF1 has an integral role in ncPRC1.3 (non-canonical Polycomb repressive complex 1.3) recruitment to chromatin in neurons, being required for AUTS2-Polycomb-mediated transcriptional activation of developmental genes. NRF1 is necessary for motor neuron differentiation from mouse embryonic stem cells in this context.","method":"AUTS2 HX domain mutation analysis, Co-IP, ChIP, motor neuron differentiation assays from mouse ESCs","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — ChIP, Co-IP, and functional differentiation assays; mechanistic link to PRC1 complex established","pmids":["34637754"],"is_preprint":false},{"year":2015,"finding":"EglN2/PHD1 forms an activator complex with PGC1α and NRF1 on chromatin to promote transcription of ferridoxin reductase (FDXR) and maintain mitochondrial function in breast cancer cells. NRF1 motif enrichment was identified in EglN2-activated genes by integrative genomic analyses.","method":"ChIP-seq, gene expression profiling, NRF1 motif enrichment analysis, EglN2 depletion, mitochondrial respiration assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq plus functional validation of complex; multiple orthogonal methods","pmids":["26492917"],"is_preprint":false},{"year":2020,"finding":"ATF4 represses NRF1 transcriptional activity by binding to the NRF1 promoter region, thereby downregulating TFAM expression and causing mitochondrial dysfunction in alcoholic liver disease.","method":"Hepatocyte-specific ATF4 knockout mice, TFAM overexpression mice, ChIP demonstrating ATF4 binding to NRF1 promoter, gene expression analysis, mitochondrial function assays","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with ChIP-validated mechanism; validated in human patient samples","pmids":["33177163"],"is_preprint":false},{"year":2023,"finding":"Virus-activated kinase TBK1 phosphorylates NRF1 at Ser318, triggering inactivation of the NRF1-TFAM axis during HSV-1 infection. A knock-in strategy mimicking TBK1-NRF1 signaling showed that interrupting this connection ablated mtDNA release and attenuated innate antiviral response.","method":"TBK1 kinase assay, site-directed mutagenesis (Ser318), knock-in mouse model, innate immune activation assays, mtDNA release measurement","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — specific phosphorylation site identified with KI mouse validation","pmids":["37409632"],"is_preprint":false},{"year":2019,"finding":"NRF1 coordinates with DNA methylation to regulate spermatogenesis; conditional NRF1 ablation in gonocytes dramatically downregulated germline genes including Asz1, blocked germ cell proliferation, and caused male infertility in mice. NRF1 binds directly to promoters of germline-specific genes.","method":"Conditional knockout mouse, ChIP, gene expression analysis, fertility phenotyping","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with ChIP and defined fertility phenotype","pmids":["28754714"],"is_preprint":false},{"year":2015,"finding":"Nrf1 is a transcriptional activator of Herpud1 (an ER homeostasis protein) through antioxidant response elements in the Herpud1 promoter; Nrf1 knockout cells show decreased Herpud1 expression and inability to induce Herpud1 in response to ER stress.","method":"Nrf1 knockout cells, transactivation reporter assays, chromatin immunoprecipitation, ER stress induction","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 2 — ChIP confirming direct binding plus KO loss-of-function with defined ER stress phenotype","pmids":["25637874"],"is_preprint":false},{"year":2009,"finding":"MCRS2 physically interacts with Nrf1 through the CNC-bZIP domain of Nrf1 (residues 354-447) and represses Nrf1-mediated transcriptional activation. MCRS2 colocalizes with Nrf1 in the nucleus without altering Nrf1 redistribution.","method":"Yeast two-hybrid screen, GST pull-down, co-immunoprecipitation, immunofluorescence, reporter gene assays","journal":"BMC cell biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple interaction assays plus functional reporter; single lab","pmids":["19187526"],"is_preprint":false},{"year":2011,"finding":"Nrf1 is ubiquitinated and degraded by the 26S proteasome; proteasomal inhibition stabilizes full-length Nrf1 but paradoxically inhibits its transactivation activity, supporting the model that the proteasome processes Nrf1 into its active form by removing its inhibitory N-terminal ER-anchoring domain. Hypoxia activates Nrf1 reporter activity.","method":"Proteasomal inhibitor treatment, immunoprecipitation for ubiquitination, EpRE-luciferase reporter assays, half-life determination, hypoxia experiments","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP ubiquitination plus reporter assays; mechanistic model supported but processing details incomplete","pmids":["22216197"],"is_preprint":false},{"year":2014,"finding":"Nrf1 physically interacts with androgen receptor (AR) and enhances AR DNA-binding activity; siRNA-mediated Nrf1 silencing attenuated AR transactivation while p65-Nrf1 overexpression enhanced it. Nrf2 suppresses AR transactivation by stimulating nuclear accumulation of p120-Nrf1.","method":"siRNA knockdown, Nrf1 overexpression, AR transactivation reporter assays, nuclear fractionation, Co-IP for Nrf1-AR interaction","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP plus functional reporter; single lab","pmids":["24466341"],"is_preprint":false},{"year":2019,"finding":"NRF1 transcriptionally activates StAR (steroidogenic acute regulatory protein) by directly binding to two NRF1-binding sites on the mouse Star promoter at positions -1445/-1422 and -44/-19, positively regulating testosterone synthesis.","method":"Dual-luciferase reporter assays, ChIP, EMSA supershift assays, site-directed mutagenesis of NRF1 binding sites, NRF1 overexpression/knockdown","journal":"The Journal of steroid biochemistry and molecular biology","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding confirmed by EMSA and ChIP with mutational validation of specific binding sites","pmids":["31028793"],"is_preprint":false},{"year":2017,"finding":"HBZ (HTLV-1 bZIP factor) physically interacts with NRF-1 and inhibits NRF-1 DNA-binding ability, thereby suppressing TDP1 gene expression; NRF-1 is identified as a direct positive transcriptional regulator of TDP1 through a conserved NRF-1 binding site in the TDP1 core promoter.","method":"Co-immunoprecipitation (HBZ-NRF1), dominant-negative NRF1, NRF1 overexpression/shRNA, TDP1 promoter reporter assays, NRF1 binding site identification","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP plus reporter assays with dominant-negative and shRNA validation","pmids":["28993637"],"is_preprint":false},{"year":2018,"finding":"LSD1-ERRα-mediated transcriptional activation at target gene TSSs requires NRF1 as an essential promoter-tethering factor for LSD1 recruitment; NRF1 does not affect LSD1 enzymatic activity. All three factors (NRF1, LSD1, ERRα) are required for cell invasion in an MMP1-dependent manner via NRF1/LSD1/ERRα-mediated H3K9me2 demethylation.","method":"ChIP-seq, siRNA knockdown of each factor, invasion assays, histone modification analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus functional invasion assays with epistasis via triple knockdown","pmids":["29968728"],"is_preprint":false},{"year":2023,"finding":"NRF1 transcriptionally induces aggrephagy by directly targeting p62/SQSTM1 and GABARAPL1 genes in response to proteasome dysfunction, in addition to its known role inducing proteasome subunit genes. NRF1 is required for p62-positive puncta formation and colocalization with ULK1 and TBK1, and for phosphorylation of p62 at Ser403.","method":"Genome-wide transcriptome analysis (RNA-seq), ChIP for direct NRF1 binding, NRF1 knockdown, p62 phosphorylation assays, confocal microscopy for puncta formation","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP plus transcriptome with mechanistic phosphorylation analysis","pmids":["37658135"],"is_preprint":false},{"year":2021,"finding":"Nrf1 genetic deletion prevented neonatal cardiomyocytes from activating a transcriptional program required for heart regeneration after injury; conversely, Nrf1 overexpression protected the adult heart from ischemia/reperfusion injury. The protective function involves dual activation of the proteasome and redox balance.","method":"Neonatal heart regeneration model, Nrf1 cardiac-specific deletion, Nrf1 overexpression, I/R injury model, cardiomyocyte toxicity assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — cardiac-specific KO plus gain-of-function with multiple defined phenotypic readouts","pmids":["34489413"],"is_preprint":false},{"year":2000,"finding":"Alpha-Pal/NRF-1 binds the FMR1 promoter and its binding is abolished by DNA methylation; USF1, USF2, and alpha-Pal/NRF-1 are the major transcription factors binding the FMR1 promoter in brain and testis extracts, and NRF-1 binding site integrity is important for transcriptional activity in neuronal cells.","method":"EMSA/supershift assays with brain and testis extracts, methylation sensitivity assays, mutational analysis of promoter binding sites, reporter gene assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct binding assays with methylation sensitivity; single lab","pmids":["11058604"],"is_preprint":false},{"year":2019,"finding":"Distinct Nrf1 isoforms (Nrf1α, Nrf1β, Nrf1γ) differentially regulate ARE target genes; Nrf1α and Nrf1β dominantly upregulate >90% of differentially expressed genes while Nrf1γ acts as a dominant-negative inhibitor, counteracting Nrf1α/β activity on target genes including 26S proteasomal subunits.","method":"Tetracycline-inducible stable expression in Flp-In T-REx system, RNA-sequencing, quantitative RT-PCR validation","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — controlled isogenic expression system with genome-wide transcriptome; single lab","pmids":["30814566"],"is_preprint":false},{"year":2005,"finding":"Alpha-Pal/NRF-1 induces neurite outgrowth in neuroblastoma cells and primary cortical neurons; a dominant-negative NRF-1 mutant inhibits neurite induction. This function is partly mediated through NRF-1's downstream target gene IAP/CD47.","method":"Stable and transient expression in IMR-32 cells, dominant-negative mutant, primary cortical neuron transfection, IAP antisense inhibition","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — gain/loss-of-function with defined phenotype plus downstream target identification; single lab","pmids":["15992771"],"is_preprint":false},{"year":2019,"finding":"NRF1 and NRF2 have overlapping and distinct transcriptional targets; ChIP-exo sequencing revealed NRF2 prefers AREs flanked by GC-rich regions while NRF1 prefers AT-rich flanking regions, explaining their differential binding in specific cellular contexts.","method":"ChIP-exo sequencing combined with RNA-seq in U2OS cells, motif analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — high-precision genome-wide binding with transcriptome analysis in three cell lines","pmids":["31628195"],"is_preprint":false},{"year":2019,"finding":"NRF1 binds subtelomeric CpG island promoters and drives TERRA (telomeric repeat-containing RNA) expression when these sites are demethylated; targeted demethylation via CRISPR-dCas9-TET1 increased TERRA production in a NRF1-dependent manner.","method":"CRISPR-dCas9-TET1 epigenetic engineering for targeted demethylation, NRF1 binding assays, TERRA quantification","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — targeted epigenetic manipulation with functional readout; single lab","pmids":["31181625"],"is_preprint":false},{"year":2024,"finding":"HDAC3 deacetylates NRF1, reducing its nuclear stability and promoting its interaction with p65/NF-κB. Pterostilbene inhibits HDAC3 activity, increasing NRF1 acetylation at K105 and K139, which inhibits NRF1-p65 interaction and reduces neuroinflammation. K105R and K139R Nrf1 mutants counteracted the protective effect.","method":"Dual-luciferase reporter, co-immunoprecipitation, site-directed mutagenesis (K105R, K139R), MCAO/R mouse model, OGD/R microglial model","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional rescue plus in vivo validation; single lab","pmids":["39198723"],"is_preprint":false},{"year":2023,"finding":"NRF1 binds the METTL3 promoter to upregulate METTL3 transcription, which promotes m6A modification and IGF2BP2-dependent mRNA stability of GLRX, protecting against dopamine neuron degeneration in a Parkinson's disease mouse model.","method":"ChIP, dual luciferase reporter assays, RIP, MeRIP (m6A profiling), NRF1/METTL3 overexpression and KD in MPTP mouse model","journal":"CNS neuroscience & therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 — direct ChIP binding with functional in vivo validation; single lab","pmids":["37735974"],"is_preprint":false},{"year":2015,"finding":"Nrf1 deficiency in pancreatic β-cells causes impaired glucose-stimulated insulin secretion, elevated basal insulin release, and oxidative stress. Mechanistically, Nrf1 loss alters glucose metabolic enzyme expression (inducing hexokinase 1, suppressing glucokinase) and disrupts coupling of glycolysis to mitochondrial metabolism.","method":"Stable Nrf1 knockdown in MIN6 cells, β-cell-specific Nrf1 conditional KO mice, insulin secretion assays, glucose metabolism assays, gene expression analysis","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 2 — conditional KO mouse plus stable KD with mechanistic gene expression analysis and multiple functional assays","pmids":["25556857"],"is_preprint":false},{"year":2010,"finding":"PGC-1β directly interacts with NRF-1 and ERRα; deletion or mutation of NRF-1 and/or ERRα binding sites in target gene (cytochrome c, ATP synthase β, ALAS-1) promoters attenuates their activation by PGC-1β. Inhibition of NRF-1 by siRNA ablates PGC-1β-mediated mitochondrial biogenesis and oxidative phosphorylation.","method":"siRNA knockdown, promoter deletion/mutagenesis, co-expression studies, mitochondrial function assays","journal":"Mitochondrion","confidence":"Medium","confidence_rationale":"Tier 2-3 — site mutagenesis plus siRNA with functional readouts; single lab","pmids":["20561910"],"is_preprint":false},{"year":2023,"finding":"NRF1 and NRF2 co-regulate genes that eliminate cholesterol and mitigate inflammation and oxidative damage in hepatocytes; combined NRF1/NRF2 deficiency (but not single deficiency) causes severe steatohepatitis, cholesterol overload, and altered bile acid metabolism. Therapeutic effects of NRF2-activating drug bardoxolone require NRF1.","method":"Hepatocyte-specific single and double KO mice, ChIP-seq for target gene identification, dietary cholesterol challenge, pharmacological bardoxolone treatment","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — conditional double-KO epistasis with ChIP-seq and pharmacological rescue","pmids":["37060561"],"is_preprint":false}],"current_model":"NRF1 (NFE2L1) is an ER-resident transcription factor that is constitutively N-glycosylated, retrotranslocated to the cytosol via the ERAD/p97 machinery, and rapidly degraded by the proteasome under basal conditions; when proteasome capacity is insufficient, retrotranslocated NRF1 escapes degradation, is proteolytically cleaved and activated by the aspartyl protease DDI2, deglycosylated by NGLY1, and enters the nucleus as a bZIP transcription factor (heterodimerizing with small Maf proteins) to drive coordinated expression of all 26S proteasome subunit genes (the 'bounce-back' response), as well as aggrephagy genes (p62, GABARAPL1), antioxidant/ARE-containing genes, and mitochondrial biogenesis genes (via the PGC-1α/NRF1/TFAM axis); its activity is modulated post-translationally by O-GlcNAcylation (OGT/HCF-1 complex), ubiquitination (including non-canonical oxyester-linked chains via SCFFBS2-ARIH1), phosphorylation by ATM (at oxidative stress, promoting nuclear translocation), acetylation (at K105/K139 regulated by HDAC3), and ubiquitin-mediated degradation triggered by the E3 ligase SIAH2 (at K230)."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing NRF1 as a methylation-sensitive transcription factor at specific promoters resolved how CpG methylation could silence NRF1-dependent genes such as FMR1 in brain and testis.","evidence":"EMSA/supershift assays with brain/testis extracts showing NRF1 binding abolished by methylation, plus reporter mutagenesis","pmids":["11058604"],"confidence":"Medium","gaps":["No genome-wide survey of methylation-NRF1 interplay at this stage","Functional consequence of NRF1 loss at FMR1 not shown in vivo"]},{"year":2003,"claim":"Demonstration that Nrf1 is essential for hepatocyte viability and antioxidant defense — and that Nrf1/Nrf2 double knockouts die embryonically with massive oxidative damage — established NRF1 as a non-redundant component of the cellular antioxidant transcription network.","evidence":"Chimeric mouse analysis for Nrf1, double-KO embryos for Nrf1/Nrf2, ROS measurements and antioxidant gene profiling","pmids":["12808106","12968018"],"confidence":"High","gaps":["Specific antioxidant target genes directly bound by NRF1 not yet identified","Relative contribution of NRF1 vs NRF2 to individual ARE targets unclear"]},{"year":2005,"claim":"Discovery that NRF1/NRF2 regulate GCLC transcription indirectly via AP-1 and NF-κB family members, and that NRF1 promotes neurite outgrowth via IAP/CD47, expanded the functional repertoire beyond simple ARE binding to include indirect transcriptional cascades and neuronal differentiation.","evidence":"Null fibroblast rescue with mutant reporters (GCLC); dominant-negative NRF1 in neuroblastoma and primary neurons (neurite outgrowth)","pmids":["15988009","15992771"],"confidence":"High","gaps":["Mechanism by which NRF1 controls AP-1/NF-κB expression not delineated","Neurite outgrowth pathway downstream of IAP/CD47 not mapped"]},{"year":2006,"claim":"Identification of the N-terminal domain (aa 1–124) as an ER-targeting signal that negatively regulates NRF1 transcriptional activity resolved why NRF1 is inactive under basal conditions and distinguished its regulation from Keap1-dependent NRF2 control.","evidence":"Immunocytochemistry with ER markers, deletion/domain-swap mutagenesis in WT and mutant MEFs","pmids":["16872277"],"confidence":"High","gaps":["Retrotranslocation mechanism not yet identified","Identity of protease releasing NRF1 from ER unknown"]},{"year":2011,"claim":"Showing that proteasome inhibition stabilizes full-length Nrf1 yet paradoxically reduces its transactivation activity supported a model in which the proteasome itself participates in NRF1 processing by removing the inhibitory N-terminal domain.","evidence":"Proteasome inhibitor treatment, ubiquitination assays, EpRE-reporter kinetics","pmids":["22216197"],"confidence":"Medium","gaps":["Exact cleavage site and responsible protease not identified","Single-lab observation without in vivo validation"]},{"year":2014,"claim":"Liver-specific Nrf1 knockout revealed NRF1 as a direct suppressor of lipid accumulation and the cystine/glutamate antiporter xCT, establishing its role in hepatic lipid homeostasis beyond antioxidant defense.","evidence":"Inducible liver-specific Nrf1 KO mouse, lipid profiling, ARE-reporter and promoter occupancy studies","pmids":["25092871"],"confidence":"High","gaps":["How NRF1 and NRF2 switch at the xCT ARE under stress not mechanistically defined","Downstream lipotoxic mediators not identified"]},{"year":2015,"claim":"Multiple studies converged to show that NRF1 links proteasome gene expression to mTORC1 signaling, cooperates with PGC-1α/EglN2 on mitochondrial gene promoters, and is required for β-cell glucose sensing — establishing NRF1 as a metabolic integrator across tissues.","evidence":"TSC-KO/rapamycin for mTORC1–NRF1 axis; ChIP-seq for EglN2–PGC-1α–NRF1 at FDXR; β-cell-specific Nrf1 cKO with insulin secretion assays","pmids":["26017155","26492917","25556857"],"confidence":"High","gaps":["Direct phosphorylation or signal transduction from mTORC1 to NRF1 protein not identified","Whether NRF1 mitochondrial targets differ across tissues unknown"]},{"year":2015,"claim":"Genome-wide DNase-seq in methylation-deficient cells proved that DNA methylation directly competes with NRF1 binding at thousands of sites, establishing a general epigenetic gating mechanism for NRF1 target selection.","evidence":"DNase-I mapping in murine ES cells ± DNA methyltransferases, motif deletion experiments","pmids":["26675734"],"confidence":"High","gaps":["Whether NRF1 actively protects bound sites from remethylation not fully resolved","Tissue-specific methylation patterns and NRF1 access not examined"]},{"year":2016,"claim":"Identification of DDI2 as the aspartyl protease required for NRF1 cleavage and activation — conserved from C. elegans to mammals — resolved the long-standing question of how NRF1 is proteolytically activated during the proteasome 'bounce-back' response.","evidence":"DDI2 KO cells with protease-dead rescue (mammalian); genetic screen and epistasis in C. elegans SKN-1A pathway","pmids":["27528193","27528192"],"confidence":"High","gaps":["Precise DDI2 cleavage site on NRF1 not mapped","Signals triggering DDI2 activation not identified"]},{"year":2016,"claim":"Demonstration that NRF1 can be retrotranslocated and cleaved even under complete proteasome blockade revealed a proteasome-independent processing route, refining the earlier model that the proteasome itself was the activating protease.","evidence":"Complete active-site proteasome inhibition with subcellular fractionation and western blot for NRF1 isoforms","pmids":["27676297"],"confidence":"Medium","gaps":["Identity of proteasome-independent processing enzyme (later shown to be DDI2) not confirmed in this study","Single-lab biochemical observation"]},{"year":2016,"claim":"Genetic evidence that small Maf triple-KO phenocopies Nrf1 liver-KO (steatosis, proteasomal gene dysregulation) proved that sMaf proteins are obligate heterodimeric partners for NRF1 function in vivo.","evidence":"Liver-specific conditional sMaf triple-KO mice with gene expression and phenotypic comparison to Nrf1 KO","pmids":["27723178"],"confidence":"High","gaps":["Relative contribution of individual sMaf isoforms not resolved","Whether sMaf availability limits NRF1 activity in non-hepatic tissues unknown"]},{"year":2018,"claim":"OGT/HCF-1-mediated O-GlcNAcylation was established as a major post-translational modifier of NRF1 stability and transcriptional output, with therapeutic implications for cancer proteasome inhibitor sensitivity.","evidence":"Reciprocal Co-IP/MS, OGT inhibition in vitro and xenograft models; replicated across three independent studies","pmids":["29941490","28625484","26231763"],"confidence":"High","gaps":["Contradictory conclusions on whether O-GlcNAcylation stabilizes or destabilizes NRF1 across studies","Specific O-GlcNAc sites beyond PEST2 domain not fully catalogued"]},{"year":2018,"claim":"Brown-adipocyte-specific Nrf1 deletion showed that NRF1-driven proteasome upregulation is essential for ER homeostasis during cold-induced thermogenesis, linking NRF1 to adaptive tissue remodeling.","evidence":"BAT-specific cKO mouse, cold exposure, proteasome activity and ER stress markers","pmids":["29400713"],"confidence":"High","gaps":["Whether NRF1 targets in BAT extend beyond proteasome subunits not fully catalogued","Upstream signal from cold to NRF1 activation not identified"]},{"year":2018,"claim":"NGLY1 deficiency was shown to impair NRF1-dependent mitophagy and trigger innate immune activation via cGAS-STING and MDA5-MAVS, connecting NRF1 deglycosylation to mitochondrial quality control and inflammation.","evidence":"NGLY1 KO in human and mouse cells, mitophagy assays, innate immune pathway measurements, NRF2 pharmacological rescue","pmids":["30135079"],"confidence":"High","gaps":["Whether NRF1 glycosylation state directly controls specific mitophagy gene promoters not shown","Contribution of NRF1 vs other NGLY1 substrates not fully deconvolved"]},{"year":2019,"claim":"ATM phosphorylation of NRF1 specifically in response to oxidative stress (not DNA damage) drives NRF1 dimerization and nuclear entry to upregulate mitochondrial genes, establishing a kinase-level switch linking ROS sensing to mitochondrial biogenesis.","evidence":"ATM activation assays distinguishing stimuli, phosphorylation assays, ATM-null cell mitochondrial function","pmids":["30642892"],"confidence":"High","gaps":["Specific NRF1 phosphorylation sites by ATM not mapped","Whether other oxidative-stress kinases also target NRF1 unknown"]},{"year":2019,"claim":"SIAH2-mediated ubiquitination at K230 degrades NRF1 under hypoxia, suppressing nuclear-encoded mitochondrial genes and promoting the Warburg effect — identifying a specific E3 ligase and degron for NRF1 turnover in cancer metabolism.","evidence":"Ubiquitination assays, K230 mutagenesis, hypoxia experiments, gene expression profiling","pmids":["30833558"],"confidence":"High","gaps":["Whether SIAH2 targets all NRF1 isoforms equally unknown","Relationship to p97/ERAD-mediated NRF1 degradation pathway not clarified"]},{"year":2019,"claim":"High-resolution ChIP-exo revealed that NRF1 and NRF2 have overlapping but distinct genomic preferences (AT-rich vs GC-rich ARE flanks), explaining differential target gene selection and isoform-specific transcriptional programs.","evidence":"ChIP-exo sequencing with RNA-seq in U2OS cells, motif analysis","pmids":["31628195"],"confidence":"High","gaps":["Whether flanking-sequence preference varies across cell types not tested","Structural basis for differential motif recognition not determined"]},{"year":2021,"claim":"NRF1 was found to be an integral component of ncPRC1.3 in neurons, required for AUTS2-Polycomb-mediated transcriptional activation and motor neuron differentiation — a function entirely distinct from its known proteostasis/metabolic roles.","evidence":"AUTS2 HX domain mutation, Co-IP, ChIP, motor neuron differentiation from mouse ESCs","pmids":["34637754"],"confidence":"High","gaps":["Whether NRF1-PRC1.3 interaction occurs in non-neuronal contexts unknown","Structural basis of NRF1 incorporation into PRC1.3 not determined"]},{"year":2021,"claim":"NRF1 was shown to couple mitochondrial biogenesis with mitophagy by transcriptionally activating FUNDC1 via PGC-1α, and to be essential for neonatal cardiac regeneration through dual proteasome and redox gene activation.","evidence":"ChIP on Fundc1 promoter plus BAT-specific Fundc1 cKO (mitophagy); cardiac-specific Nrf1 deletion plus overexpression in I/R model","pmids":["33554448","34489413"],"confidence":"High","gaps":["Full repertoire of NRF1 mitophagy targets beyond FUNDC1 not defined","Whether NRF1's cardiac role requires DDI2-mediated activation not tested"]},{"year":2022,"claim":"Genome-wide characterization of the Nrf1-MafG heterodimer binding (CsMBEs) revealed that proteasome subunit genes are part of a broader proteostasis transcriptional network (ERAD, chaperones, ubiquitin pathway), with SINE B2 transposable elements contributing binding site diversity.","evidence":"Tethered Nrf1-MafG in sMaf triple-KO fibroblasts, ChIP-seq, RNA-seq","pmids":["35129372"],"confidence":"High","gaps":["Whether SINE B2-derived CsMBEs are functional in all tissues not assessed","Chromatin accessibility requirements for CsMBE activity not examined"]},{"year":2023,"claim":"NRF1 was shown to directly induce aggrephagy genes (p62, GABARAPL1) during proteasome dysfunction, expanding the bounce-back response beyond proteasome subunit transcription to include selective autophagy — and NRF1/NRF2 co-regulation of cholesterol elimination genes was revealed by double-KO hepatocytes.","evidence":"RNA-seq and ChIP for NRF1 on p62/GABARAPL1 promoters; hepatocyte-specific NRF1/NRF2 double-KO with ChIP-seq and cholesterol challenge","pmids":["37658135","37060561"],"confidence":"High","gaps":["Relative contribution of aggrephagy vs proteasome upregulation to cellular survival not quantified","Mechanism of NRF1/NRF2 cooperativity at cholesterol gene promoters not defined"]},{"year":2023,"claim":"TBK1 phosphorylation of NRF1 at Ser318 during viral infection inactivates the NRF1-TFAM axis, suppressing mtDNA release and attenuating innate antiviral responses — identifying NRF1 as a pathogen-targeted node linking mitochondrial integrity to immunity.","evidence":"Kinase assay, Ser318 mutagenesis, knock-in mouse model, mtDNA release and innate immune measurements","pmids":["37409632"],"confidence":"High","gaps":["Whether other viruses exploit TBK1-NRF1 axis not tested","Interplay between TBK1 and ATM phosphorylation of NRF1 not examined"]},{"year":2024,"claim":"Discovery that SCF^FBS2 and ARIH1 cooperate to attach non-canonical oxyester-linked ubiquitin chains to NRF1's N-GlcNAc residues — inhibiting DDI2-mediated activation — revealed an unexpected glycan-dependent ubiquitin code controlling the bounce-back response.","evidence":"In vitro reconstitution on glycopeptides, cell-based ubiquitination, mass spectrometry, mutagenesis","pmids":["39116872"],"confidence":"High","gaps":["Physiological contexts in which oxyester ubiquitination dominates over canonical degradation unknown","Whether ENGASE-generated N-GlcNAc is the sole trigger for this pathway not confirmed"]},{"year":2024,"claim":"HDAC3-mediated deacetylation of NRF1 at K105/K139 was shown to reduce nuclear NRF1 stability and promote NRF1-p65 interaction driving neuroinflammation, identifying acetylation as yet another post-translational layer of NRF1 regulation.","evidence":"K105R/K139R mutagenesis, Co-IP, dual-luciferase reporter, MCAO/R mouse stroke model","pmids":["39198723"],"confidence":"Medium","gaps":["Single-lab study; independent replication needed","Whether acetylation and O-GlcNAcylation compete at overlapping sites not examined"]},{"year":null,"claim":"Despite extensive characterization of NRF1 activation, the precise DDI2 cleavage site on NRF1, the structural basis for NRF1-sMaf DNA recognition at CsMBEs versus AREs, the integration logic among competing post-translational modifications (O-GlcNAcylation, oxyester ubiquitination, phosphorylation, acetylation), and whether NRF1's PRC1.3-associated role extends beyond neurons remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["DDI2 cleavage site on NRF1 not mapped","No structural model of NRF1-sMaf-DNA complex","Integration of competing PTMs not systematically analyzed","Tissue scope of NRF1-PRC1.3 function unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,3,5,13,17,18,19,20,33,36,38,44]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,20,25,30,35,38,39]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,8,9]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[11,21,27,40]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8,28]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,17,18,19,20,33,36,38,44]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,3,5,9,13,28,33]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[41]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[11,12,14,22,23,24,43]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[15,16,26]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[12,14,33]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[4,21]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[18,42,44]}],"complexes":["NRF1-sMaf heterodimer","OGT-HCF-1-NRF1 complex","ncPRC1.3"],"partners":["DDI2","MAFG","OGT","HCF1","SIAH2","ARIH1","AUTS2","MCRS2"],"other_free_text":[]},"mechanistic_narrative":"NRF1 (also known as NFE2L1 or alpha-Pal/NRF-1) is a CNC-bZIP transcription factor that serves as a master regulator of proteasome homeostasis, antioxidant defense, and mitochondrial biogenesis, coordinating cellular proteostasis with metabolic adaptation. NRF1 is synthesized as an ER-resident glycoprotein anchored by its N-terminal domain; upon proteasome insufficiency it is retrotranslocated to the cytosol, proteolytically cleaved and activated by the aspartyl protease DDI2, deglycosylated by NGLY1, and translocated to the nucleus where it heterodimerizes with small Maf proteins to bind CNC-sMaf-binding elements (CsMBEs) and antioxidant response elements (AREs), driving expression of all 26S proteasome subunit genes, aggrephagy mediators (p62, GABARAPL1), ER homeostasis factors, and cholesterol-elimination genes [PMID:27528193, PMID:27528192, PMID:27676297, PMID:27723178, PMID:35129372, PMID:37658135, PMID:37060561]. NRF1 activity is tuned by O-GlcNAcylation (OGT/HCF-1 complex), non-canonical oxyester-linked ubiquitination (SCF^FBS2–ARIH1), SIAH2-mediated degradation at K230, ATM-dependent phosphorylation promoting nuclear entry under oxidative stress, TBK1 phosphorylation at Ser318 inactivating the NRF1–TFAM axis during viral infection, and HDAC3-mediated deacetylation at K105/K139 [PMID:29941490, PMID:39116872, PMID:30833558, PMID:30642892, PMID:37409632, PMID:39198723]. Beyond proteostasis, NRF1 cooperates with PGC-1α/β and ERRα to activate nuclear-encoded mitochondrial genes (TFAM, cytochrome c, FDXR, FUNDC1), is essential for hepatocyte survival and lipid homeostasis, drives spermatogenesis and cardiac regeneration programs, and recruits ncPRC1.3 for neuronal developmental gene activation [PMID:33554448, PMID:26492917, PMID:20561910, PMID:12808106, PMID:25092871, PMID:28754714, PMID:34489413, PMID:34637754]."},"prefetch_data":{"uniprot":{"accession":"Q16656","full_name":"Nuclear respiratory factor 1","aliases":["Alpha palindromic-binding protein","Alpha-pal"],"length_aa":503,"mass_kda":53.5,"function":"Transcription factor that activates the expression of the EIF2S1 (EIF2-alpha) gene. Links the transcriptional modulation of key metabolic genes to cellular growth and development. Implicated in the control of nuclear genes required for respiration, heme biosynthesis, and mitochondrial DNA transcription and replication","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q16656/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/NRF1","classification":"Common Essential","n_dependent_lines":1182,"n_total_lines":1208,"dependency_fraction":0.9784768211920529},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NRF1","total_profiled":1310},"omim":[{"mim_id":"620871","title":"DNA DAMAGE-INDUCIBLE 1 HOMOLOG 2; DDI2","url":"https://www.omim.org/entry/620871"},{"mim_id":"618217","title":"EGFR LONG NONCODING DOWNSTREAM RNA; ELDR","url":"https://www.omim.org/entry/618217"},{"mim_id":"617462","title":"PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA, COACTIVATOR-RELATED PROTEIN 1; PPRC1","url":"https://www.omim.org/entry/617462"},{"mim_id":"616855","title":"CYTOCHROME c OXIDASE, SUBUNIT 8C; COX8C","url":"https://www.omim.org/entry/616855"},{"mim_id":"616498","title":"RETICULOPHAGY REGULATOR FAMILY, MEMBER 3; RETREG3","url":"https://www.omim.org/entry/616498"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NRF1"},"hgnc":{"alias_symbol":["EWG","ALPHA-PAL"],"prev_symbol":[]},"alphafold":{"accession":"Q16656","domains":[{"cath_id":"-","chopping":"57-173","consensus_level":"high","plddt":87.1174,"start":57,"end":173},{"cath_id":"-","chopping":"196-277","consensus_level":"high","plddt":91.6271,"start":196,"end":277},{"cath_id":"-","chopping":"308-332","consensus_level":"medium","plddt":48.1584,"start":308,"end":332}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16656","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16656-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16656-F1-predicted_aligned_error_v6.png","plddt_mean":57.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NRF1","jax_strain_url":"https://www.jax.org/strain/search?query=NRF1"},"sequence":{"accession":"Q16656","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16656.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16656/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16656"}},"corpus_meta":[{"pmid":"12832613","id":"PMC_12832613","title":"Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12832613","citation_count":1610,"is_preprint":false},{"pmid":"26675734","id":"PMC_26675734","title":"Competition between DNA methylation and transcription factors determines binding of NRF1.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26675734","citation_count":377,"is_preprint":false},{"pmid":"12968018","id":"PMC_12968018","title":"Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12968018","citation_count":267,"is_preprint":false},{"pmid":"15988009","id":"PMC_15988009","title":"Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15988009","citation_count":216,"is_preprint":false},{"pmid":"27528192","id":"PMC_27528192","title":"Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27528192","citation_count":194,"is_preprint":false},{"pmid":"29400713","id":"PMC_29400713","title":"Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity.","date":"2018","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29400713","citation_count":166,"is_preprint":false},{"pmid":"27528193","id":"PMC_27528193","title":"The aspartyl protease DDI2 activates Nrf1 to compensate for proteasome dysfunction.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27528193","citation_count":150,"is_preprint":false},{"pmid":"33554448","id":"PMC_33554448","title":"Mitophagy receptor FUNDC1 is regulated by PGC-1α/NRF1 to fine tune mitochondrial homeostasis.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/33554448","citation_count":131,"is_preprint":false},{"pmid":"20561910","id":"PMC_20561910","title":"PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERR alpha.","date":"2010","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/20561910","citation_count":126,"is_preprint":false},{"pmid":"12808106","id":"PMC_12808106","title":"Nrf1 is critical for redox balance and survival of liver cells during development.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12808106","citation_count":125,"is_preprint":false},{"pmid":"33177163","id":"PMC_33177163","title":"ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis.","date":"2020","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/33177163","citation_count":120,"is_preprint":false},{"pmid":"30135079","id":"PMC_30135079","title":"N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1.","date":"2018","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30135079","citation_count":104,"is_preprint":false},{"pmid":"16872277","id":"PMC_16872277","title":"Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16872277","citation_count":102,"is_preprint":false},{"pmid":"34489413","id":"PMC_34489413","title":"Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34489413","citation_count":100,"is_preprint":false},{"pmid":"14522950","id":"PMC_14522950","title":"ELAV inhibits 3'-end processing to promote neural splicing of ewg pre-mRNA.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/14522950","citation_count":77,"is_preprint":false},{"pmid":"11058604","id":"PMC_11058604","title":"Interaction of the transcription factors USF1, USF2, and alpha -Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11058604","citation_count":77,"is_preprint":false},{"pmid":"26017155","id":"PMC_26017155","title":"mTORC1 signaling activates NRF1 to increase cellular proteasome levels.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/26017155","citation_count":76,"is_preprint":false},{"pmid":"32732978","id":"PMC_32732978","title":"Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32732978","citation_count":76,"is_preprint":false},{"pmid":"27983596","id":"PMC_27983596","title":"Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases.","date":"2016","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27983596","citation_count":73,"is_preprint":false},{"pmid":"30973820","id":"PMC_30973820","title":"Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30973820","citation_count":71,"is_preprint":false},{"pmid":"30333037","id":"PMC_30333037","title":"Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis.","date":"2018","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/30333037","citation_count":71,"is_preprint":false},{"pmid":"25092871","id":"PMC_25092871","title":"Transcription factor Nrf1 negatively regulates the cystine/glutamate transporter and lipid-metabolizing enzymes.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25092871","citation_count":70,"is_preprint":false},{"pmid":"26492917","id":"PMC_26492917","title":"EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer.","date":"2015","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26492917","citation_count":69,"is_preprint":false},{"pmid":"30833558","id":"PMC_30833558","title":"The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30833558","citation_count":67,"is_preprint":false},{"pmid":"31628195","id":"PMC_31628195","title":"Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31628195","citation_count":67,"is_preprint":false},{"pmid":"28582729","id":"PMC_28582729","title":"The role of Nrf1 and Nrf2 in the regulation of glutathione and redox dynamics in the developing zebrafish embryo.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28582729","citation_count":66,"is_preprint":false},{"pmid":"26254094","id":"PMC_26254094","title":"Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and prevention.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26254094","citation_count":65,"is_preprint":false},{"pmid":"26962150","id":"PMC_26962150","title":"A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26962150","citation_count":61,"is_preprint":false},{"pmid":"30642892","id":"PMC_30642892","title":"ATM is activated by ATP depletion and modulates mitochondrial function through NRF1.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30642892","citation_count":60,"is_preprint":false},{"pmid":"29941490","id":"PMC_29941490","title":"O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29941490","citation_count":59,"is_preprint":false},{"pmid":"24466341","id":"PMC_24466341","title":"Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24466341","citation_count":57,"is_preprint":false},{"pmid":"25556857","id":"PMC_25556857","title":"CNC-bZIP protein Nrf1-dependent regulation of glucose-stimulated insulin secretion.","date":"2015","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/25556857","citation_count":57,"is_preprint":false},{"pmid":"33096892","id":"PMC_33096892","title":"Defining the Functional Targets of Cap'n'collar Transcription Factors NRF1, NRF2, and NRF3.","date":"2020","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33096892","citation_count":57,"is_preprint":false},{"pmid":"16107705","id":"PMC_16107705","title":"ELAV multimerizes on conserved AU4-6 motifs important for ewg splicing regulation.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16107705","citation_count":56,"is_preprint":false},{"pmid":"23316324","id":"PMC_23316324","title":"Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1/2 and antioxidant response.","date":"2012","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/23316324","citation_count":50,"is_preprint":false},{"pmid":"24462598","id":"PMC_24462598","title":"The role of Nrf1 and Nrf2 in the regulation of copper-responsive transcription.","date":"2014","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/24462598","citation_count":49,"is_preprint":false},{"pmid":"35940907","id":"PMC_35940907","title":"Regulation and Functions of the ER-Associated Nrf1 Transcription Factor.","date":"2023","source":"Cold Spring Harbor perspectives in biology","url":"https://pubmed.ncbi.nlm.nih.gov/35940907","citation_count":46,"is_preprint":false},{"pmid":"37409632","id":"PMC_37409632","title":"NRF1-mediated mitochondrial biogenesis antagonizes innate antiviral immunity.","date":"2023","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/37409632","citation_count":44,"is_preprint":false},{"pmid":"30047092","id":"PMC_30047092","title":"Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.","date":"2018","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/30047092","citation_count":43,"is_preprint":false},{"pmid":"34637754","id":"PMC_34637754","title":"NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/34637754","citation_count":43,"is_preprint":false},{"pmid":"35876654","id":"PMC_35876654","title":"LINC00839 promotes colorectal cancer progression by recruiting RUVBL1/Tip60 complexes to activate NRF1.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/35876654","citation_count":43,"is_preprint":false},{"pmid":"33535386","id":"PMC_33535386","title":"Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33535386","citation_count":42,"is_preprint":false},{"pmid":"28754714","id":"PMC_28754714","title":"NRF1 coordinates with DNA methylation to regulate spermatogenesis.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28754714","citation_count":42,"is_preprint":false},{"pmid":"25637874","id":"PMC_25637874","title":"Induction of Herpud1 expression by ER stress is regulated by Nrf1.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/25637874","citation_count":42,"is_preprint":false},{"pmid":"30267745","id":"PMC_30267745","title":"Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases.","date":"2018","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30267745","citation_count":41,"is_preprint":false},{"pmid":"33508374","id":"PMC_33508374","title":"CLTRN, Regulated by NRF1/RAN/DLD Protein Complex, Enhances Radiation Sensitivity of Hepatocellular Carcinoma Cells Through Ferroptosis Pathway.","date":"2021","source":"International journal of radiation oncology, biology, physics","url":"https://pubmed.ncbi.nlm.nih.gov/33508374","citation_count":40,"is_preprint":false},{"pmid":"35704676","id":"PMC_35704676","title":"NRF1-mediated microglial activation triggers high-altitude cerebral edema.","date":"2022","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35704676","citation_count":38,"is_preprint":false},{"pmid":"31931283","id":"PMC_31931283","title":"Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARγ expression.","date":"2019","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/31931283","citation_count":38,"is_preprint":false},{"pmid":"32456207","id":"PMC_32456207","title":"ER-Resident Transcription Factor Nrf1 Regulates Proteasome Expression and Beyond.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32456207","citation_count":35,"is_preprint":false},{"pmid":"30305478","id":"PMC_30305478","title":"Transcriptional regulation of the 26S proteasome by Nrf1.","date":"2018","source":"Proceedings of the Japan Academy. Series B, Physical and biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30305478","citation_count":35,"is_preprint":false},{"pmid":"30172371","id":"PMC_30172371","title":"Resistin destroys mitochondrial biogenesis by inhibiting the PGC-1α/ NRF1/TFAM signaling pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30172371","citation_count":35,"is_preprint":false},{"pmid":"25779891","id":"PMC_25779891","title":"Expression of Mitochondria-Associated Genes (PPARGC1A, NRF-1, BCL-2 and BAX) in Follicular Development and Atresia of Goat Ovaries.","date":"2015","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/25779891","citation_count":35,"is_preprint":false},{"pmid":"24198395","id":"PMC_24198395","title":"Drosophila Erect wing (Ewg) controls mitochondrial fusion during muscle growth and maintenance by regulation of the Opa1-like gene.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/24198395","citation_count":33,"is_preprint":false},{"pmid":"27345029","id":"PMC_27345029","title":"TCF11/Nrf1-Mediated Induction of Proteasome Expression Prevents Cytotoxicity by Rotenone.","date":"2016","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27345029","citation_count":33,"is_preprint":false},{"pmid":"31947743","id":"PMC_31947743","title":"Disabling the Protease DDI2 Attenuates the Transcriptional Activity of NRF1 and Potentiates Proteasome Inhibitor Cytotoxicity.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31947743","citation_count":33,"is_preprint":false},{"pmid":"24281119","id":"PMC_24281119","title":"The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells.","date":"2010","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/24281119","citation_count":32,"is_preprint":false},{"pmid":"33276082","id":"PMC_33276082","title":"The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinoma.","date":"2020","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33276082","citation_count":31,"is_preprint":false},{"pmid":"28624767","id":"PMC_28624767","title":"Effects of NRF1 on steroidogenesis and apoptosis in goat luteinized granulosa cells.","date":"2017","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28624767","citation_count":30,"is_preprint":false},{"pmid":"32344880","id":"PMC_32344880","title":"Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32344880","citation_count":30,"is_preprint":false},{"pmid":"28625484","id":"PMC_28625484","title":"Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase.","date":"2017","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28625484","citation_count":30,"is_preprint":false},{"pmid":"32924844","id":"PMC_32924844","title":"Regulation of NRF1, a master transcription factor of proteasome genes: implications for cancer and neurodegeneration.","date":"2020","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/32924844","citation_count":30,"is_preprint":false},{"pmid":"36071454","id":"PMC_36071454","title":"Long noncoding RNA LINC01132 enhances immunosuppression and therapy resistance via NRF1/DPP4 axis in hepatocellular carcinoma.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/36071454","citation_count":29,"is_preprint":false},{"pmid":"15992771","id":"PMC_15992771","title":"A novel function of transcription factor alpha-Pal/NRF-1: increasing neurite outgrowth.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15992771","citation_count":29,"is_preprint":false},{"pmid":"27676297","id":"PMC_27676297","title":"Nrf1 can be processed and activated in a proteasome-independent manner.","date":"2016","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/27676297","citation_count":29,"is_preprint":false},{"pmid":"22216197","id":"PMC_22216197","title":"The Nrf1 CNC-bZIP protein is regulated by the proteasome and activated by hypoxia.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22216197","citation_count":28,"is_preprint":false},{"pmid":"26231763","id":"PMC_26231763","title":"Transcription factor Nrf1 is negatively regulated by its O-GlcNAcylation status.","date":"2015","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/26231763","citation_count":28,"is_preprint":false},{"pmid":"34649278","id":"PMC_34649278","title":"Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival.","date":"2022","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/34649278","citation_count":28,"is_preprint":false},{"pmid":"37658135","id":"PMC_37658135","title":"The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis.","date":"2023","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/37658135","citation_count":27,"is_preprint":false},{"pmid":"35251464","id":"PMC_35251464","title":"ACEA Attenuates Oxidative Stress by Promoting Mitophagy via CB1R/Nrf1/PINK1 Pathway after Subarachnoid Hemorrhage in Rats.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35251464","citation_count":27,"is_preprint":false},{"pmid":"39116872","id":"PMC_39116872","title":"Sugar-mediated non-canonical ubiquitination impairs Nrf1/NFE2L1 activation.","date":"2024","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/39116872","citation_count":26,"is_preprint":false},{"pmid":"40025022","id":"PMC_40025022","title":"Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation.","date":"2025","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40025022","citation_count":26,"is_preprint":false},{"pmid":"10330140","id":"PMC_10330140","title":"Differential and inefficient splicing of a broadly expressed Drosophila erect wing transcript results in tissue-specific enrichment of the vital EWG protein isoform.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10330140","citation_count":26,"is_preprint":false},{"pmid":"30814566","id":"PMC_30814566","title":"Distinct isoforms of Nrf1 diversely regulate different subsets of its cognate target genes.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30814566","citation_count":24,"is_preprint":false},{"pmid":"32810507","id":"PMC_32810507","title":"NRF-1 and HIF-1α contribute to modulation of human VDAC1 gene promoter during starvation and hypoxia in HeLa cells.","date":"2020","source":"Biochimica et biophysica acta. Bioenergetics","url":"https://pubmed.ncbi.nlm.nih.gov/32810507","citation_count":24,"is_preprint":false},{"pmid":"36989111","id":"PMC_36989111","title":"The N6-methyladenine DNA demethylase ALKBH1 promotes gastric carcinogenesis by disrupting NRF1 binding capacity.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36989111","citation_count":23,"is_preprint":false},{"pmid":"25976310","id":"PMC_25976310","title":"Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25976310","citation_count":23,"is_preprint":false},{"pmid":"37060561","id":"PMC_37060561","title":"Complementary gene regulation by NRF1 and NRF2 protects against hepatic cholesterol overload.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37060561","citation_count":22,"is_preprint":false},{"pmid":"35032049","id":"PMC_35032049","title":"Curcumin attenuates isoniazid-induced hepatotoxicity by upregulating the SIRT1/PGC-1α/NRF1 pathway.","date":"2022","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/35032049","citation_count":22,"is_preprint":false},{"pmid":"37735974","id":"PMC_37735974","title":"NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6 A methylation through upregulation of METTL3 transcription.","date":"2023","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/37735974","citation_count":22,"is_preprint":false},{"pmid":"19187526","id":"PMC_19187526","title":"MCRS2 represses the transactivation activities of Nrf1.","date":"2009","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19187526","citation_count":22,"is_preprint":false},{"pmid":"36009254","id":"PMC_36009254","title":"Distinct Roles of Nrf1 and Nrf2 in Monitoring the Reductive Stress Response to Dithiothreitol (DTT).","date":"2022","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36009254","citation_count":21,"is_preprint":false},{"pmid":"38901196","id":"PMC_38901196","title":"Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway.","date":"2024","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/38901196","citation_count":20,"is_preprint":false},{"pmid":"23892277","id":"PMC_23892277","title":"Estradiol and tamoxifen regulate NRF-1 and mitochondrial function in mouse mammary gland and uterus.","date":"2013","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23892277","citation_count":20,"is_preprint":false},{"pmid":"35455387","id":"PMC_35455387","title":"Paeoniflorin Alleviates Skeletal Muscle Atrophy in Ovariectomized Mice through the ERα/NRF1 Mitochondrial Biogenesis Pathway.","date":"2022","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35455387","citation_count":20,"is_preprint":false},{"pmid":"21705751","id":"PMC_21705751","title":"ELAV-mediated 3'-end processing of ewg transcripts is evolutionarily conserved despite sequence degeneration of the ELAV-binding site.","date":"2011","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21705751","citation_count":20,"is_preprint":false},{"pmid":"27723178","id":"PMC_27723178","title":"Small Maf deficiency recapitulates the liver phenotypes of Nrf1- and Nrf2-deficient mice.","date":"2016","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/27723178","citation_count":19,"is_preprint":false},{"pmid":"39198723","id":"PMC_39198723","title":"Pterostilbene improves neurological dysfunction and neuroinflammation after ischaemic stroke via HDAC3/Nrf1-mediated microglial activation.","date":"2024","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/39198723","citation_count":18,"is_preprint":false},{"pmid":"38346661","id":"PMC_38346661","title":"Potential effect of acupuncture on mitochondrial biogenesis, energy metabolism and oxidation stress in MCAO rat via PGC-1α/NRF1/TFAM pathway.","date":"2024","source":"Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","url":"https://pubmed.ncbi.nlm.nih.gov/38346661","citation_count":18,"is_preprint":false},{"pmid":"23939472","id":"PMC_23939472","title":"Novel genes FAM134C, C3orf10 and ENOX1 are regulated by NRF-1 and differentially regulate neurite outgrowth in neuroblastoma cells and hippocampal neurons.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23939472","citation_count":17,"is_preprint":false},{"pmid":"36436616","id":"PMC_36436616","title":"PGC-1α/NRF1-dependent cardiac mitochondrial biogenesis: A druggable pathway of calycosin against triptolide cardiotoxicity.","date":"2022","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/36436616","citation_count":17,"is_preprint":false},{"pmid":"21053274","id":"PMC_21053274","title":"Prolonged Nrf1 overexpression triggers adipocyte inflammation and insulin resistance.","date":"2010","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21053274","citation_count":17,"is_preprint":false},{"pmid":"31181625","id":"PMC_31181625","title":"Repression of TERRA Expression by Subtelomeric DNA Methylation Is Dependent on NRF1 Binding.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31181625","citation_count":16,"is_preprint":false},{"pmid":"31028793","id":"PMC_31028793","title":"Transcription regulation of NRF1 on StAR reduces testosterone synthesis in hypoxemic murine.","date":"2019","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31028793","citation_count":16,"is_preprint":false},{"pmid":"36591497","id":"PMC_36591497","title":"Agrimol B inhibits colon carcinoma progression by blocking mitochondrial function through the PGC-1α/NRF1/TFAM signaling pathway.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36591497","citation_count":16,"is_preprint":false},{"pmid":"33592266","id":"PMC_33592266","title":"The positive regulation loop between NRF1 and NONO-TFE3 fusion promotes phase separation and aggregation of NONO-TFE3 in NONO-TFE3 tRCC.","date":"2021","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33592266","citation_count":16,"is_preprint":false},{"pmid":"35129372","id":"PMC_35129372","title":"Target Gene Diversity of the Nrf1-MafG Transcription Factor Revealed by a Tethered Heterodimer.","date":"2022","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35129372","citation_count":15,"is_preprint":false},{"pmid":"29968728","id":"PMC_29968728","title":"LSD1-ERRα complex requires NRF1 to positively regulate transcription and cell invasion.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29968728","citation_count":15,"is_preprint":false},{"pmid":"31470059","id":"PMC_31470059","title":"T-2 toxin upregulates the expression of human cytochrome P450 1A1 (CYP1A1) by enhancing NRF1 and Sp1 interaction.","date":"2019","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31470059","citation_count":15,"is_preprint":false},{"pmid":"32705174","id":"PMC_32705174","title":"Downregulation of miR‑486‑5p alleviates LPS‑induced inflammatory injury, oxidative stress and apoptosis in Chondrogenic cell ATDC5 by targeting NRF1.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32705174","citation_count":15,"is_preprint":false},{"pmid":"28993637","id":"PMC_28993637","title":"HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28993637","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51634,"output_tokens":10459,"usd":0.155893},"stage2":{"model":"claude-opus-4-6","input_tokens":14501,"output_tokens":6197,"usd":0.341145},"total_usd":0.497038,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"Nrf1 is targeted to the endoplasmic reticulum via its N-terminal domain (NTD, amino acids 1-124), which negatively regulates its activity by anchoring it to the ER. Keap1 does not control Nrf1 activity or subcellular distribution, distinguishing Nrf1 regulation from Nrf2. Attachment of the NTD to Nrf2 redirected Nrf2 from the nucleus to the ER.\",\n      \"method\": \"Immunocytochemistry with ER marker co-localization, ectopic expression of wild-type and deletion mutants in wild-type and mutant MEFs, domain-swap experiments\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (immunocytochemistry, mutagenesis, domain-swap) in single rigorous study\",\n      \"pmids\": [\"16872277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The aspartyl protease DDI2 (DNA-damage inducible 1 homolog 2) is required to proteolytically cleave and activate Nrf1 in response to proteasome dysfunction. Deletion of DDI2 reduced the cleaved form of Nrf1 and impaired proteasome subunit upregulation; protease-dead DDI2 could not rescue these defects.\",\n      \"method\": \"DDI2 knockout cell lines, add-back of wild-type vs. protease-dead DDI2 mutant, western blot for Nrf1 cleavage forms, proteasome activity assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic deletion plus protease-dead rescue experiment; independently replicated in two simultaneous publications (PMID 27528192 and 27528193)\",\n      \"pmids\": [\"27528193\", \"27528192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In C. elegans, ER-associated SKN-1A/Nrf1 is activated by the aspartic protease DDI-1, which cleaves it following proteasome dysfunction. Genes required for SKN-1A activation include regulators of ER traffic and a peptide N-glycanase, establishing a conserved ER-to-nucleus proteasome surveillance pathway.\",\n      \"method\": \"Comprehensive genetic screen (C. elegans), epistasis analysis, protease requirement assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — comprehensive genetic epistasis in C. elegans ortholog; conserved mechanism confirmed in parallel mammalian work\",\n      \"pmids\": [\"27528192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"mTORC1 activation promotes NRF1-dependent transcriptional upregulation of proteasome subunit genes, increasing cellular proteasome content. This was demonstrated through genetic activation of mTORC1 (TSC loss-of-function) as well as physiological stimuli (growth factors, feeding).\",\n      \"method\": \"Genetic loss-of-function (TSC knockout), pharmacological mTORC1 inhibition with rapamycin, NRF1 knockdown, proteasome content measurements\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined cellular phenotype, but single lab report\",\n      \"pmids\": [\"26017155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DNA methylation competes with NRF1 binding in vivo; NRF1 occupies thousands of additional sites in unmethylated genomes. Restoring de novo methyltransferase activity initiates remethylation at NRF1-bound sites and outcompetes NRF1 binding. Removal of neighboring motifs in cis or a cooperating TF in trans causes local hypermethylation and loss of NRF1 binding.\",\n      \"method\": \"DNase-I hypersensitive site mapping in murine stem cells with/without DNA methylation, genetic manipulation of methyltransferases, motif deletion experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide mapping with multiple orthogonal genetic manipulations; published in high-impact journal\",\n      \"pmids\": [\"26675734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"O-GlcNAc transferase (OGT) and host cell factor C1 (HCF-1) form a complex with NRF1; O-GlcNAcylation catalyzed by OGT stabilizes NRF1 and is essential for NRF1-mediated upregulation of proteasome subunit genes. OGT inhibition sensitized cancer cells to proteasome inhibitors in vitro and in xenograft models.\",\n      \"method\": \"Immunoprecipitation and mass spectrometry, OGT inhibition, xenograft mouse model, meta-analysis of cancer proteomics data\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP/MS identification plus functional in vivo validation\",\n      \"pmids\": [\"29941490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nrf1 is negatively regulated by O-GlcNAcylation via OGT interaction through HCF-1; O-GlcNAcylation decreases Nrf1 protein stability and transactivation activity by promoting ubiquitination. The PEST2 degron within Nrf1 is identified as the O-GlcNAcylation site.\",\n      \"method\": \"Co-immunoprecipitation, OGT overexpression, proteasomal inhibition, ubiquitination assays, domain mapping\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with functional follow-up; single lab but multiple methods\",\n      \"pmids\": [\"28625484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nrf1 O-GlcNAcylation by OGT negatively regulates Nrf1/TCF11 protein stability and transactivation activity, promoting ubiquitination and turnover. This effect is glucose-concentration dependent.\",\n      \"method\": \"OGT interaction identified by pulldown, co-immunoprecipitation, ubiquitination assays, reporter assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP/pulldown with functional follow-up; replicated in PMID 28625484\",\n      \"pmids\": [\"26231763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Under conditions of complete proteasome blockade, Nrf1 (p120) can still be retrotranslocated into the cytosol and proteolytically cleaved to the active p110 form in a proteasome-independent manner, indicating a proteasome-independent processing pathway exists.\",\n      \"method\": \"Complete proteasome active-site inhibition, subcellular fractionation, western blot for Nrf1 processing forms, transcription reporter assays\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean biochemical demonstration with complete proteasome blockade; single lab\",\n      \"pmids\": [\"27676297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SCFFBS2 (an N-glycan-recognizing E3 ligase) cooperates with the RBR-type E3 ligase ARIH1 to ubiquitinate Nrf1 through oxyester bonds (non-canonical ubiquitination) at N-GlcNAc residues generated by ENGASE. This atypical ubiquitin chain assembly requires UBE2L3 and inhibits DDI2-mediated Nrf1 activation.\",\n      \"method\": \"In vitro reconstitution of polyubiquitination on glycopeptides, cell-based ubiquitination assays, mass spectrometry, mutagenesis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution plus mutagenesis plus cell-based validation\",\n      \"pmids\": [\"39116872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIAH2, a hypoxia-activated E3 ubiquitin ligase, degrades NRF1 through ubiquitination on lysine 230, reducing nuclear-encoded mitochondrial gene expression including pyruvate dehydrogenase beta, promoting the Warburg effect and metabolic reprogramming.\",\n      \"method\": \"Ubiquitination assays, site-directed mutagenesis (K230), hypoxia experiments, gene expression profiling, tumor microenvironment analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — specific ubiquitination site identified with mutagenesis and functional consequence demonstrated\",\n      \"pmids\": [\"30833558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATM, when activated by oxidative stress (but not by DNA damage), phosphorylates NRF1, leading to NRF1 dimerization, nuclear translocation, and upregulation of nuclear-encoded mitochondrial genes to enhance electron transport chain capacity and restore mitochondrial function.\",\n      \"method\": \"ATM activation assays distinguishing oxidative vs. DNA damage stimuli, phosphorylation assays, subcellular fractionation, mitochondrial function assays in ATM-null cells\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — specific kinase-substrate relationship with mechanistic dissection of stimulus type; multiple orthogonal assays\",\n      \"pmids\": [\"30642892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PGC-1α and NRF1 transcriptionally upregulate FUNDC1 (a mitophagy receptor) by NRF1 binding to the consensus site in the Fundc1 promoter, coupling mitochondrial biogenesis with mitophagy. Specific knockout of Fundc1 in BAT impaired mitochondrial turnover and adaptive thermogenesis.\",\n      \"method\": \"ChIP demonstrating NRF1 binding to Fundc1 promoter, conditional knockout mouse, mitochondrial function assays, thermogenesis phenotyping\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with direct promoter binding plus conditional KO with defined metabolic phenotype\",\n      \"pmids\": [\"33554448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cold adaptation induces Nrf1 in brown adipose tissue (BAT) to increase proteasomal activity, which is crucial for maintaining ER homeostasis during thermogenic activity. Brown-adipocyte-specific deletion of Nrf1 caused ER stress, tissue inflammation, diminished mitochondrial function, and BAT whitening under thermogenic conditions.\",\n      \"method\": \"Tissue-specific conditional knockout mouse, cold exposure experiments, proteasome activity assays, ER stress markers, mitochondrial function measurements\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with multiple defined mechanistic readouts\",\n      \"pmids\": [\"29400713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NGLY1 regulates mitochondrial homeostasis through NRF1; NGLY1-deficient cells show impaired mitophagy and fragmented mitochondria with cGAS-STING and MDA5-MAVS pathway activation. Pharmacological activation of NRF2 (a non-glycosylated homolog) restores mitochondrial homeostasis in NGLY1-deficient cells.\",\n      \"method\": \"NGLY1 knockout human and mouse cells, mitophagy assays, innate immune pathway activation measurements, NRF1 functional rescue experiments\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO in multiple cell types with mechanistic pathway delineation and rescue\",\n      \"pmids\": [\"30135079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Nrf1 is essential for hepatocyte survival during development; Nrf1-deficient cells contributed to fetal but not adult liver. Loss of Nrf1 caused liver cell apoptosis, increased oxidative stress, impaired antioxidant gene expression, and sensitized cells to TNF-mediated cytotoxicity.\",\n      \"method\": \"Chimeric mouse analysis, primary hepatocyte culture, oxidative stress measurements, antioxidant gene expression assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo chimera analysis plus primary cell functional assays; clean loss-of-function with defined phenotype\",\n      \"pmids\": [\"12808106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Nrf1 and Nrf2 have overlapping functions in antioxidant gene expression during early development; compound Nrf1/Nrf2 double-knockout mice die at E9-10 with extensive apoptosis and severely impaired antioxidant defense gene expression compared with single knockouts. Cell death was mediated by ROS activation of p53/Noxa.\",\n      \"method\": \"Double-knockout mouse generation, reactive oxygen species measurement, antioxidant gene expression, rescue by reduced oxygen or antioxidants, p53/Noxa induction assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via double-KO with multiple mechanistic readouts\",\n      \"pmids\": [\"12968018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Nrf1 and Nrf2 regulate rat GCLC transcription indirectly by modulating the expression of key AP-1 (c-Jun, c-Fos) and NF-κB (p50, p65) family members. Overexpression of Nrf1 or Nrf2 restored GCLC promoter activity but not if AP-1 and NF-κB binding sites were mutated.\",\n      \"method\": \"Nrf1/Nrf2 null fibroblasts, reporter gene assays with site-directed mutagenesis, mRNA/protein expression analysis, nuclear binding activity assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis of response elements plus null-cell rescue; multiple orthogonal approaches\",\n      \"pmids\": [\"15988009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Liver-specific Nrf1 knockout causes lipid accumulation in hepatocytes with altered fatty acid composition due to upregulation of FA metabolism genes. Nrf1 normally suppresses the cystine/glutamate antiporter xCT by occupying an ARE in its promoter; upon severe oxidative stress, Nrf1 is displaced and Nrf2 is recruited.\",\n      \"method\": \"Inducible liver-specific Nrf1 knockout mouse, lipid analysis, gene expression profiling, ARE reporter assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO mouse with detailed molecular mechanism including promoter occupancy studies\",\n      \"pmids\": [\"25092871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Small Maf (sMaf) proteins are indispensable heterodimeric partners for Nrf1 in the liver; liver-specific sMaf triple-deficient mice recapitulate the Nrf1 liver-specific KO phenotype (hepatic steatosis, dysregulation of metabolic and proteasomal genes), providing genetic evidence that sMaf proteins mediate Nrf1 function.\",\n      \"method\": \"Liver-specific conditional sMaf triple-knockout mice, gene expression profiling, phenotypic comparison with Nrf1 KO\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via conditional triple-KO recapitulating Nrf1 phenotype\",\n      \"pmids\": [\"27723178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The Nrf1-MafG heterodimer binds CNC-sMaf-binding elements (CsMBEs) to activate proteasome subunit genes and broader proteostasis-related genes (ER-associated degradation, chaperone, ubiquitin-mediated degradation pathways). SINE B2 transposable elements harbor CsMBEs and contribute to target gene diversity.\",\n      \"method\": \"Tethered Nrf1-MafG heterodimer in small Maf triple-knockout fibroblasts, ChIP-seq, RNA-seq\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide binding and transcriptome analysis with engineered heterodimer system\",\n      \"pmids\": [\"35129372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NRF1 has an integral role in ncPRC1.3 (non-canonical Polycomb repressive complex 1.3) recruitment to chromatin in neurons, being required for AUTS2-Polycomb-mediated transcriptional activation of developmental genes. NRF1 is necessary for motor neuron differentiation from mouse embryonic stem cells in this context.\",\n      \"method\": \"AUTS2 HX domain mutation analysis, Co-IP, ChIP, motor neuron differentiation assays from mouse ESCs\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP, Co-IP, and functional differentiation assays; mechanistic link to PRC1 complex established\",\n      \"pmids\": [\"34637754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EglN2/PHD1 forms an activator complex with PGC1α and NRF1 on chromatin to promote transcription of ferridoxin reductase (FDXR) and maintain mitochondrial function in breast cancer cells. NRF1 motif enrichment was identified in EglN2-activated genes by integrative genomic analyses.\",\n      \"method\": \"ChIP-seq, gene expression profiling, NRF1 motif enrichment analysis, EglN2 depletion, mitochondrial respiration assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus functional validation of complex; multiple orthogonal methods\",\n      \"pmids\": [\"26492917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"ATF4 represses NRF1 transcriptional activity by binding to the NRF1 promoter region, thereby downregulating TFAM expression and causing mitochondrial dysfunction in alcoholic liver disease.\",\n      \"method\": \"Hepatocyte-specific ATF4 knockout mice, TFAM overexpression mice, ChIP demonstrating ATF4 binding to NRF1 promoter, gene expression analysis, mitochondrial function assays\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with ChIP-validated mechanism; validated in human patient samples\",\n      \"pmids\": [\"33177163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Virus-activated kinase TBK1 phosphorylates NRF1 at Ser318, triggering inactivation of the NRF1-TFAM axis during HSV-1 infection. A knock-in strategy mimicking TBK1-NRF1 signaling showed that interrupting this connection ablated mtDNA release and attenuated innate antiviral response.\",\n      \"method\": \"TBK1 kinase assay, site-directed mutagenesis (Ser318), knock-in mouse model, innate immune activation assays, mtDNA release measurement\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — specific phosphorylation site identified with KI mouse validation\",\n      \"pmids\": [\"37409632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NRF1 coordinates with DNA methylation to regulate spermatogenesis; conditional NRF1 ablation in gonocytes dramatically downregulated germline genes including Asz1, blocked germ cell proliferation, and caused male infertility in mice. NRF1 binds directly to promoters of germline-specific genes.\",\n      \"method\": \"Conditional knockout mouse, ChIP, gene expression analysis, fertility phenotyping\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with ChIP and defined fertility phenotype\",\n      \"pmids\": [\"28754714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nrf1 is a transcriptional activator of Herpud1 (an ER homeostasis protein) through antioxidant response elements in the Herpud1 promoter; Nrf1 knockout cells show decreased Herpud1 expression and inability to induce Herpud1 in response to ER stress.\",\n      \"method\": \"Nrf1 knockout cells, transactivation reporter assays, chromatin immunoprecipitation, ER stress induction\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming direct binding plus KO loss-of-function with defined ER stress phenotype\",\n      \"pmids\": [\"25637874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MCRS2 physically interacts with Nrf1 through the CNC-bZIP domain of Nrf1 (residues 354-447) and represses Nrf1-mediated transcriptional activation. MCRS2 colocalizes with Nrf1 in the nucleus without altering Nrf1 redistribution.\",\n      \"method\": \"Yeast two-hybrid screen, GST pull-down, co-immunoprecipitation, immunofluorescence, reporter gene assays\",\n      \"journal\": \"BMC cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple interaction assays plus functional reporter; single lab\",\n      \"pmids\": [\"19187526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nrf1 is ubiquitinated and degraded by the 26S proteasome; proteasomal inhibition stabilizes full-length Nrf1 but paradoxically inhibits its transactivation activity, supporting the model that the proteasome processes Nrf1 into its active form by removing its inhibitory N-terminal ER-anchoring domain. Hypoxia activates Nrf1 reporter activity.\",\n      \"method\": \"Proteasomal inhibitor treatment, immunoprecipitation for ubiquitination, EpRE-luciferase reporter assays, half-life determination, hypoxia experiments\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP ubiquitination plus reporter assays; mechanistic model supported but processing details incomplete\",\n      \"pmids\": [\"22216197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nrf1 physically interacts with androgen receptor (AR) and enhances AR DNA-binding activity; siRNA-mediated Nrf1 silencing attenuated AR transactivation while p65-Nrf1 overexpression enhanced it. Nrf2 suppresses AR transactivation by stimulating nuclear accumulation of p120-Nrf1.\",\n      \"method\": \"siRNA knockdown, Nrf1 overexpression, AR transactivation reporter assays, nuclear fractionation, Co-IP for Nrf1-AR interaction\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP plus functional reporter; single lab\",\n      \"pmids\": [\"24466341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NRF1 transcriptionally activates StAR (steroidogenic acute regulatory protein) by directly binding to two NRF1-binding sites on the mouse Star promoter at positions -1445/-1422 and -44/-19, positively regulating testosterone synthesis.\",\n      \"method\": \"Dual-luciferase reporter assays, ChIP, EMSA supershift assays, site-directed mutagenesis of NRF1 binding sites, NRF1 overexpression/knockdown\",\n      \"journal\": \"The Journal of steroid biochemistry and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding confirmed by EMSA and ChIP with mutational validation of specific binding sites\",\n      \"pmids\": [\"31028793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HBZ (HTLV-1 bZIP factor) physically interacts with NRF-1 and inhibits NRF-1 DNA-binding ability, thereby suppressing TDP1 gene expression; NRF-1 is identified as a direct positive transcriptional regulator of TDP1 through a conserved NRF-1 binding site in the TDP1 core promoter.\",\n      \"method\": \"Co-immunoprecipitation (HBZ-NRF1), dominant-negative NRF1, NRF1 overexpression/shRNA, TDP1 promoter reporter assays, NRF1 binding site identification\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP plus reporter assays with dominant-negative and shRNA validation\",\n      \"pmids\": [\"28993637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"LSD1-ERRα-mediated transcriptional activation at target gene TSSs requires NRF1 as an essential promoter-tethering factor for LSD1 recruitment; NRF1 does not affect LSD1 enzymatic activity. All three factors (NRF1, LSD1, ERRα) are required for cell invasion in an MMP1-dependent manner via NRF1/LSD1/ERRα-mediated H3K9me2 demethylation.\",\n      \"method\": \"ChIP-seq, siRNA knockdown of each factor, invasion assays, histone modification analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus functional invasion assays with epistasis via triple knockdown\",\n      \"pmids\": [\"29968728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NRF1 transcriptionally induces aggrephagy by directly targeting p62/SQSTM1 and GABARAPL1 genes in response to proteasome dysfunction, in addition to its known role inducing proteasome subunit genes. NRF1 is required for p62-positive puncta formation and colocalization with ULK1 and TBK1, and for phosphorylation of p62 at Ser403.\",\n      \"method\": \"Genome-wide transcriptome analysis (RNA-seq), ChIP for direct NRF1 binding, NRF1 knockdown, p62 phosphorylation assays, confocal microscopy for puncta formation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP plus transcriptome with mechanistic phosphorylation analysis\",\n      \"pmids\": [\"37658135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Nrf1 genetic deletion prevented neonatal cardiomyocytes from activating a transcriptional program required for heart regeneration after injury; conversely, Nrf1 overexpression protected the adult heart from ischemia/reperfusion injury. The protective function involves dual activation of the proteasome and redox balance.\",\n      \"method\": \"Neonatal heart regeneration model, Nrf1 cardiac-specific deletion, Nrf1 overexpression, I/R injury model, cardiomyocyte toxicity assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cardiac-specific KO plus gain-of-function with multiple defined phenotypic readouts\",\n      \"pmids\": [\"34489413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Alpha-Pal/NRF-1 binds the FMR1 promoter and its binding is abolished by DNA methylation; USF1, USF2, and alpha-Pal/NRF-1 are the major transcription factors binding the FMR1 promoter in brain and testis extracts, and NRF-1 binding site integrity is important for transcriptional activity in neuronal cells.\",\n      \"method\": \"EMSA/supershift assays with brain and testis extracts, methylation sensitivity assays, mutational analysis of promoter binding sites, reporter gene assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding assays with methylation sensitivity; single lab\",\n      \"pmids\": [\"11058604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Distinct Nrf1 isoforms (Nrf1α, Nrf1β, Nrf1γ) differentially regulate ARE target genes; Nrf1α and Nrf1β dominantly upregulate >90% of differentially expressed genes while Nrf1γ acts as a dominant-negative inhibitor, counteracting Nrf1α/β activity on target genes including 26S proteasomal subunits.\",\n      \"method\": \"Tetracycline-inducible stable expression in Flp-In T-REx system, RNA-sequencing, quantitative RT-PCR validation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — controlled isogenic expression system with genome-wide transcriptome; single lab\",\n      \"pmids\": [\"30814566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Alpha-Pal/NRF-1 induces neurite outgrowth in neuroblastoma cells and primary cortical neurons; a dominant-negative NRF-1 mutant inhibits neurite induction. This function is partly mediated through NRF-1's downstream target gene IAP/CD47.\",\n      \"method\": \"Stable and transient expression in IMR-32 cells, dominant-negative mutant, primary cortical neuron transfection, IAP antisense inhibition\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — gain/loss-of-function with defined phenotype plus downstream target identification; single lab\",\n      \"pmids\": [\"15992771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NRF1 and NRF2 have overlapping and distinct transcriptional targets; ChIP-exo sequencing revealed NRF2 prefers AREs flanked by GC-rich regions while NRF1 prefers AT-rich flanking regions, explaining their differential binding in specific cellular contexts.\",\n      \"method\": \"ChIP-exo sequencing combined with RNA-seq in U2OS cells, motif analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — high-precision genome-wide binding with transcriptome analysis in three cell lines\",\n      \"pmids\": [\"31628195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NRF1 binds subtelomeric CpG island promoters and drives TERRA (telomeric repeat-containing RNA) expression when these sites are demethylated; targeted demethylation via CRISPR-dCas9-TET1 increased TERRA production in a NRF1-dependent manner.\",\n      \"method\": \"CRISPR-dCas9-TET1 epigenetic engineering for targeted demethylation, NRF1 binding assays, TERRA quantification\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — targeted epigenetic manipulation with functional readout; single lab\",\n      \"pmids\": [\"31181625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HDAC3 deacetylates NRF1, reducing its nuclear stability and promoting its interaction with p65/NF-κB. Pterostilbene inhibits HDAC3 activity, increasing NRF1 acetylation at K105 and K139, which inhibits NRF1-p65 interaction and reduces neuroinflammation. K105R and K139R Nrf1 mutants counteracted the protective effect.\",\n      \"method\": \"Dual-luciferase reporter, co-immunoprecipitation, site-directed mutagenesis (K105R, K139R), MCAO/R mouse model, OGD/R microglial model\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional rescue plus in vivo validation; single lab\",\n      \"pmids\": [\"39198723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NRF1 binds the METTL3 promoter to upregulate METTL3 transcription, which promotes m6A modification and IGF2BP2-dependent mRNA stability of GLRX, protecting against dopamine neuron degeneration in a Parkinson's disease mouse model.\",\n      \"method\": \"ChIP, dual luciferase reporter assays, RIP, MeRIP (m6A profiling), NRF1/METTL3 overexpression and KD in MPTP mouse model\",\n      \"journal\": \"CNS neuroscience & therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct ChIP binding with functional in vivo validation; single lab\",\n      \"pmids\": [\"37735974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Nrf1 deficiency in pancreatic β-cells causes impaired glucose-stimulated insulin secretion, elevated basal insulin release, and oxidative stress. Mechanistically, Nrf1 loss alters glucose metabolic enzyme expression (inducing hexokinase 1, suppressing glucokinase) and disrupts coupling of glycolysis to mitochondrial metabolism.\",\n      \"method\": \"Stable Nrf1 knockdown in MIN6 cells, β-cell-specific Nrf1 conditional KO mice, insulin secretion assays, glucose metabolism assays, gene expression analysis\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO mouse plus stable KD with mechanistic gene expression analysis and multiple functional assays\",\n      \"pmids\": [\"25556857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PGC-1β directly interacts with NRF-1 and ERRα; deletion or mutation of NRF-1 and/or ERRα binding sites in target gene (cytochrome c, ATP synthase β, ALAS-1) promoters attenuates their activation by PGC-1β. Inhibition of NRF-1 by siRNA ablates PGC-1β-mediated mitochondrial biogenesis and oxidative phosphorylation.\",\n      \"method\": \"siRNA knockdown, promoter deletion/mutagenesis, co-expression studies, mitochondrial function assays\",\n      \"journal\": \"Mitochondrion\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — site mutagenesis plus siRNA with functional readouts; single lab\",\n      \"pmids\": [\"20561910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NRF1 and NRF2 co-regulate genes that eliminate cholesterol and mitigate inflammation and oxidative damage in hepatocytes; combined NRF1/NRF2 deficiency (but not single deficiency) causes severe steatohepatitis, cholesterol overload, and altered bile acid metabolism. Therapeutic effects of NRF2-activating drug bardoxolone require NRF1.\",\n      \"method\": \"Hepatocyte-specific single and double KO mice, ChIP-seq for target gene identification, dietary cholesterol challenge, pharmacological bardoxolone treatment\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional double-KO epistasis with ChIP-seq and pharmacological rescue\",\n      \"pmids\": [\"37060561\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NRF1 (NFE2L1) is an ER-resident transcription factor that is constitutively N-glycosylated, retrotranslocated to the cytosol via the ERAD/p97 machinery, and rapidly degraded by the proteasome under basal conditions; when proteasome capacity is insufficient, retrotranslocated NRF1 escapes degradation, is proteolytically cleaved and activated by the aspartyl protease DDI2, deglycosylated by NGLY1, and enters the nucleus as a bZIP transcription factor (heterodimerizing with small Maf proteins) to drive coordinated expression of all 26S proteasome subunit genes (the 'bounce-back' response), as well as aggrephagy genes (p62, GABARAPL1), antioxidant/ARE-containing genes, and mitochondrial biogenesis genes (via the PGC-1α/NRF1/TFAM axis); its activity is modulated post-translationally by O-GlcNAcylation (OGT/HCF-1 complex), ubiquitination (including non-canonical oxyester-linked chains via SCFFBS2-ARIH1), phosphorylation by ATM (at oxidative stress, promoting nuclear translocation), acetylation (at K105/K139 regulated by HDAC3), and ubiquitin-mediated degradation triggered by the E3 ligase SIAH2 (at K230).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NRF1 (also known as NFE2L1 or alpha-Pal/NRF-1) is a CNC-bZIP transcription factor that serves as a master regulator of proteasome homeostasis, antioxidant defense, and mitochondrial biogenesis, coordinating cellular proteostasis with metabolic adaptation. NRF1 is synthesized as an ER-resident glycoprotein anchored by its N-terminal domain; upon proteasome insufficiency it is retrotranslocated to the cytosol, proteolytically cleaved and activated by the aspartyl protease DDI2, deglycosylated by NGLY1, and translocated to the nucleus where it heterodimerizes with small Maf proteins to bind CNC-sMaf-binding elements (CsMBEs) and antioxidant response elements (AREs), driving expression of all 26S proteasome subunit genes, aggrephagy mediators (p62, GABARAPL1), ER homeostasis factors, and cholesterol-elimination genes [PMID:27528193, PMID:27528192, PMID:27676297, PMID:27723178, PMID:35129372, PMID:37658135, PMID:37060561]. NRF1 activity is tuned by O-GlcNAcylation (OGT/HCF-1 complex), non-canonical oxyester-linked ubiquitination (SCF^FBS2–ARIH1), SIAH2-mediated degradation at K230, ATM-dependent phosphorylation promoting nuclear entry under oxidative stress, TBK1 phosphorylation at Ser318 inactivating the NRF1–TFAM axis during viral infection, and HDAC3-mediated deacetylation at K105/K139 [PMID:29941490, PMID:39116872, PMID:30833558, PMID:30642892, PMID:37409632, PMID:39198723]. Beyond proteostasis, NRF1 cooperates with PGC-1α/β and ERRα to activate nuclear-encoded mitochondrial genes (TFAM, cytochrome c, FDXR, FUNDC1), is essential for hepatocyte survival and lipid homeostasis, drives spermatogenesis and cardiac regeneration programs, and recruits ncPRC1.3 for neuronal developmental gene activation [PMID:33554448, PMID:26492917, PMID:20561910, PMID:12808106, PMID:25092871, PMID:28754714, PMID:34489413, PMID:34637754].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing NRF1 as a methylation-sensitive transcription factor at specific promoters resolved how CpG methylation could silence NRF1-dependent genes such as FMR1 in brain and testis.\",\n      \"evidence\": \"EMSA/supershift assays with brain/testis extracts showing NRF1 binding abolished by methylation, plus reporter mutagenesis\",\n      \"pmids\": [\"11058604\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genome-wide survey of methylation-NRF1 interplay at this stage\", \"Functional consequence of NRF1 loss at FMR1 not shown in vivo\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration that Nrf1 is essential for hepatocyte viability and antioxidant defense — and that Nrf1/Nrf2 double knockouts die embryonically with massive oxidative damage — established NRF1 as a non-redundant component of the cellular antioxidant transcription network.\",\n      \"evidence\": \"Chimeric mouse analysis for Nrf1, double-KO embryos for Nrf1/Nrf2, ROS measurements and antioxidant gene profiling\",\n      \"pmids\": [\"12808106\", \"12968018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific antioxidant target genes directly bound by NRF1 not yet identified\", \"Relative contribution of NRF1 vs NRF2 to individual ARE targets unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery that NRF1/NRF2 regulate GCLC transcription indirectly via AP-1 and NF-κB family members, and that NRF1 promotes neurite outgrowth via IAP/CD47, expanded the functional repertoire beyond simple ARE binding to include indirect transcriptional cascades and neuronal differentiation.\",\n      \"evidence\": \"Null fibroblast rescue with mutant reporters (GCLC); dominant-negative NRF1 in neuroblastoma and primary neurons (neurite outgrowth)\",\n      \"pmids\": [\"15988009\", \"15992771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which NRF1 controls AP-1/NF-κB expression not delineated\", \"Neurite outgrowth pathway downstream of IAP/CD47 not mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of the N-terminal domain (aa 1–124) as an ER-targeting signal that negatively regulates NRF1 transcriptional activity resolved why NRF1 is inactive under basal conditions and distinguished its regulation from Keap1-dependent NRF2 control.\",\n      \"evidence\": \"Immunocytochemistry with ER markers, deletion/domain-swap mutagenesis in WT and mutant MEFs\",\n      \"pmids\": [\"16872277\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Retrotranslocation mechanism not yet identified\", \"Identity of protease releasing NRF1 from ER unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing that proteasome inhibition stabilizes full-length Nrf1 yet paradoxically reduces its transactivation activity supported a model in which the proteasome itself participates in NRF1 processing by removing the inhibitory N-terminal domain.\",\n      \"evidence\": \"Proteasome inhibitor treatment, ubiquitination assays, EpRE-reporter kinetics\",\n      \"pmids\": [\"22216197\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Exact cleavage site and responsible protease not identified\", \"Single-lab observation without in vivo validation\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Liver-specific Nrf1 knockout revealed NRF1 as a direct suppressor of lipid accumulation and the cystine/glutamate antiporter xCT, establishing its role in hepatic lipid homeostasis beyond antioxidant defense.\",\n      \"evidence\": \"Inducible liver-specific Nrf1 KO mouse, lipid profiling, ARE-reporter and promoter occupancy studies\",\n      \"pmids\": [\"25092871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NRF1 and NRF2 switch at the xCT ARE under stress not mechanistically defined\", \"Downstream lipotoxic mediators not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Multiple studies converged to show that NRF1 links proteasome gene expression to mTORC1 signaling, cooperates with PGC-1α/EglN2 on mitochondrial gene promoters, and is required for β-cell glucose sensing — establishing NRF1 as a metabolic integrator across tissues.\",\n      \"evidence\": \"TSC-KO/rapamycin for mTORC1–NRF1 axis; ChIP-seq for EglN2–PGC-1α–NRF1 at FDXR; β-cell-specific Nrf1 cKO with insulin secretion assays\",\n      \"pmids\": [\"26017155\", \"26492917\", \"25556857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation or signal transduction from mTORC1 to NRF1 protein not identified\", \"Whether NRF1 mitochondrial targets differ across tissues unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Genome-wide DNase-seq in methylation-deficient cells proved that DNA methylation directly competes with NRF1 binding at thousands of sites, establishing a general epigenetic gating mechanism for NRF1 target selection.\",\n      \"evidence\": \"DNase-I mapping in murine ES cells ± DNA methyltransferases, motif deletion experiments\",\n      \"pmids\": [\"26675734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NRF1 actively protects bound sites from remethylation not fully resolved\", \"Tissue-specific methylation patterns and NRF1 access not examined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of DDI2 as the aspartyl protease required for NRF1 cleavage and activation — conserved from C. elegans to mammals — resolved the long-standing question of how NRF1 is proteolytically activated during the proteasome 'bounce-back' response.\",\n      \"evidence\": \"DDI2 KO cells with protease-dead rescue (mammalian); genetic screen and epistasis in C. elegans SKN-1A pathway\",\n      \"pmids\": [\"27528193\", \"27528192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise DDI2 cleavage site on NRF1 not mapped\", \"Signals triggering DDI2 activation not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstration that NRF1 can be retrotranslocated and cleaved even under complete proteasome blockade revealed a proteasome-independent processing route, refining the earlier model that the proteasome itself was the activating protease.\",\n      \"evidence\": \"Complete active-site proteasome inhibition with subcellular fractionation and western blot for NRF1 isoforms\",\n      \"pmids\": [\"27676297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of proteasome-independent processing enzyme (later shown to be DDI2) not confirmed in this study\", \"Single-lab biochemical observation\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genetic evidence that small Maf triple-KO phenocopies Nrf1 liver-KO (steatosis, proteasomal gene dysregulation) proved that sMaf proteins are obligate heterodimeric partners for NRF1 function in vivo.\",\n      \"evidence\": \"Liver-specific conditional sMaf triple-KO mice with gene expression and phenotypic comparison to Nrf1 KO\",\n      \"pmids\": [\"27723178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of individual sMaf isoforms not resolved\", \"Whether sMaf availability limits NRF1 activity in non-hepatic tissues unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"OGT/HCF-1-mediated O-GlcNAcylation was established as a major post-translational modifier of NRF1 stability and transcriptional output, with therapeutic implications for cancer proteasome inhibitor sensitivity.\",\n      \"evidence\": \"Reciprocal Co-IP/MS, OGT inhibition in vitro and xenograft models; replicated across three independent studies\",\n      \"pmids\": [\"29941490\", \"28625484\", \"26231763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contradictory conclusions on whether O-GlcNAcylation stabilizes or destabilizes NRF1 across studies\", \"Specific O-GlcNAc sites beyond PEST2 domain not fully catalogued\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Brown-adipocyte-specific Nrf1 deletion showed that NRF1-driven proteasome upregulation is essential for ER homeostasis during cold-induced thermogenesis, linking NRF1 to adaptive tissue remodeling.\",\n      \"evidence\": \"BAT-specific cKO mouse, cold exposure, proteasome activity and ER stress markers\",\n      \"pmids\": [\"29400713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NRF1 targets in BAT extend beyond proteasome subunits not fully catalogued\", \"Upstream signal from cold to NRF1 activation not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"NGLY1 deficiency was shown to impair NRF1-dependent mitophagy and trigger innate immune activation via cGAS-STING and MDA5-MAVS, connecting NRF1 deglycosylation to mitochondrial quality control and inflammation.\",\n      \"evidence\": \"NGLY1 KO in human and mouse cells, mitophagy assays, innate immune pathway measurements, NRF2 pharmacological rescue\",\n      \"pmids\": [\"30135079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NRF1 glycosylation state directly controls specific mitophagy gene promoters not shown\", \"Contribution of NRF1 vs other NGLY1 substrates not fully deconvolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"ATM phosphorylation of NRF1 specifically in response to oxidative stress (not DNA damage) drives NRF1 dimerization and nuclear entry to upregulate mitochondrial genes, establishing a kinase-level switch linking ROS sensing to mitochondrial biogenesis.\",\n      \"evidence\": \"ATM activation assays distinguishing stimuli, phosphorylation assays, ATM-null cell mitochondrial function\",\n      \"pmids\": [\"30642892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific NRF1 phosphorylation sites by ATM not mapped\", \"Whether other oxidative-stress kinases also target NRF1 unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"SIAH2-mediated ubiquitination at K230 degrades NRF1 under hypoxia, suppressing nuclear-encoded mitochondrial genes and promoting the Warburg effect — identifying a specific E3 ligase and degron for NRF1 turnover in cancer metabolism.\",\n      \"evidence\": \"Ubiquitination assays, K230 mutagenesis, hypoxia experiments, gene expression profiling\",\n      \"pmids\": [\"30833558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SIAH2 targets all NRF1 isoforms equally unknown\", \"Relationship to p97/ERAD-mediated NRF1 degradation pathway not clarified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"High-resolution ChIP-exo revealed that NRF1 and NRF2 have overlapping but distinct genomic preferences (AT-rich vs GC-rich ARE flanks), explaining differential target gene selection and isoform-specific transcriptional programs.\",\n      \"evidence\": \"ChIP-exo sequencing with RNA-seq in U2OS cells, motif analysis\",\n      \"pmids\": [\"31628195\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether flanking-sequence preference varies across cell types not tested\", \"Structural basis for differential motif recognition not determined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"NRF1 was found to be an integral component of ncPRC1.3 in neurons, required for AUTS2-Polycomb-mediated transcriptional activation and motor neuron differentiation — a function entirely distinct from its known proteostasis/metabolic roles.\",\n      \"evidence\": \"AUTS2 HX domain mutation, Co-IP, ChIP, motor neuron differentiation from mouse ESCs\",\n      \"pmids\": [\"34637754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NRF1-PRC1.3 interaction occurs in non-neuronal contexts unknown\", \"Structural basis of NRF1 incorporation into PRC1.3 not determined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"NRF1 was shown to couple mitochondrial biogenesis with mitophagy by transcriptionally activating FUNDC1 via PGC-1α, and to be essential for neonatal cardiac regeneration through dual proteasome and redox gene activation.\",\n      \"evidence\": \"ChIP on Fundc1 promoter plus BAT-specific Fundc1 cKO (mitophagy); cardiac-specific Nrf1 deletion plus overexpression in I/R model\",\n      \"pmids\": [\"33554448\", \"34489413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of NRF1 mitophagy targets beyond FUNDC1 not defined\", \"Whether NRF1's cardiac role requires DDI2-mediated activation not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Genome-wide characterization of the Nrf1-MafG heterodimer binding (CsMBEs) revealed that proteasome subunit genes are part of a broader proteostasis transcriptional network (ERAD, chaperones, ubiquitin pathway), with SINE B2 transposable elements contributing binding site diversity.\",\n      \"evidence\": \"Tethered Nrf1-MafG in sMaf triple-KO fibroblasts, ChIP-seq, RNA-seq\",\n      \"pmids\": [\"35129372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SINE B2-derived CsMBEs are functional in all tissues not assessed\", \"Chromatin accessibility requirements for CsMBE activity not examined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"NRF1 was shown to directly induce aggrephagy genes (p62, GABARAPL1) during proteasome dysfunction, expanding the bounce-back response beyond proteasome subunit transcription to include selective autophagy — and NRF1/NRF2 co-regulation of cholesterol elimination genes was revealed by double-KO hepatocytes.\",\n      \"evidence\": \"RNA-seq and ChIP for NRF1 on p62/GABARAPL1 promoters; hepatocyte-specific NRF1/NRF2 double-KO with ChIP-seq and cholesterol challenge\",\n      \"pmids\": [\"37658135\", \"37060561\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of aggrephagy vs proteasome upregulation to cellular survival not quantified\", \"Mechanism of NRF1/NRF2 cooperativity at cholesterol gene promoters not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"TBK1 phosphorylation of NRF1 at Ser318 during viral infection inactivates the NRF1-TFAM axis, suppressing mtDNA release and attenuating innate antiviral responses — identifying NRF1 as a pathogen-targeted node linking mitochondrial integrity to immunity.\",\n      \"evidence\": \"Kinase assay, Ser318 mutagenesis, knock-in mouse model, mtDNA release and innate immune measurements\",\n      \"pmids\": [\"37409632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other viruses exploit TBK1-NRF1 axis not tested\", \"Interplay between TBK1 and ATM phosphorylation of NRF1 not examined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that SCF^FBS2 and ARIH1 cooperate to attach non-canonical oxyester-linked ubiquitin chains to NRF1's N-GlcNAc residues — inhibiting DDI2-mediated activation — revealed an unexpected glycan-dependent ubiquitin code controlling the bounce-back response.\",\n      \"evidence\": \"In vitro reconstitution on glycopeptides, cell-based ubiquitination, mass spectrometry, mutagenesis\",\n      \"pmids\": [\"39116872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts in which oxyester ubiquitination dominates over canonical degradation unknown\", \"Whether ENGASE-generated N-GlcNAc is the sole trigger for this pathway not confirmed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"HDAC3-mediated deacetylation of NRF1 at K105/K139 was shown to reduce nuclear NRF1 stability and promote NRF1-p65 interaction driving neuroinflammation, identifying acetylation as yet another post-translational layer of NRF1 regulation.\",\n      \"evidence\": \"K105R/K139R mutagenesis, Co-IP, dual-luciferase reporter, MCAO/R mouse stroke model\",\n      \"pmids\": [\"39198723\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study; independent replication needed\", \"Whether acetylation and O-GlcNAcylation compete at overlapping sites not examined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Despite extensive characterization of NRF1 activation, the precise DDI2 cleavage site on NRF1, the structural basis for NRF1-sMaf DNA recognition at CsMBEs versus AREs, the integration logic among competing post-translational modifications (O-GlcNAcylation, oxyester ubiquitination, phosphorylation, acetylation), and whether NRF1's PRC1.3-associated role extends beyond neurons remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"DDI2 cleavage site on NRF1 not mapped\", \"No structural model of NRF1-sMaf-DNA complex\", \"Integration of competing PTMs not systematically analyzed\", \"Tissue scope of NRF1-PRC1.3 function unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 3, 5, 13, 17, 18, 19, 20, 33, 36, 38, 44]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 20, 25, 30, 35, 38, 39]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 8, 9]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11, 21, 27, 40]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 17, 18, 19, 20, 33, 36, 38, 44]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 3, 5, 9, 13, 28, 33]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [41]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [11, 12, 14, 22, 23, 24, 43]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [15, 16, 26]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [12, 14, 33]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [4, 21]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [18, 42, 44]}\n    ],\n    \"complexes\": [\n      \"NRF1-sMaf heterodimer\",\n      \"OGT-HCF-1-NRF1 complex\",\n      \"ncPRC1.3\"\n    ],\n    \"partners\": [\n      \"DDI2\",\n      \"MAFG\",\n      \"OGT\",\n      \"HCF1\",\n      \"SIAH2\",\n      \"ARIH1\",\n      \"AUTS2\",\n      \"MCRS2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}